NewzIntel.com

Category: COVID-19 Vaccine

  • MIL-OSI China: UNICEF chief says UN-led humanitarian action in Gaza sidelined

    Source: People’s Republic of China – State Council News

    The UN-led humanitarian response in Gaza has been sidelined since the breakdown of the ceasefire in March, even though the world body was doing a good job, said UN Children’s Fund (UNICEF) Executive Director Catherine Russell on Wednesday.

    “For the last several months, the UN-led humanitarian response has been sidelined despite the fact that during the March ceasefire, we were delivering assistance in an efficient and safe manner,” she told a Security Council meeting on the humanitarian situation in Gaza.

    Essential vaccines and neonatal care, lifesaving nutrition services, and access to clean water were affected, she said, and asked members of the Security Council to ensure that UNICEF and their humanitarian partners are allowed to do their jobs.

    “We have proven that essentials like medicine, vaccines, water, food, and nutrition for babies can reach those in need, wherever they are, when we have appropriate access. We urgently need a return to the functioning UN-led aid pipeline with safe and sustained humanitarian access through all available (border) crossings,” said Russell.

    Also, she reiterated the UN secretary-general’s appeal to ensure that all aid delivery is demilitarized and grounded in the principles of humanity, impartiality, neutrality and independence.

    Russell was referring to the militarized mode of humanitarian aid distribution carried out by the Gaza Humanitarian Foundation, run by the United States, which set up four sites in the whole of Gaza in restricted Israeli military zones where starving civilians enter through fenced lanes under the eyes of armed security contractors.

    Between May 27 and July 7, the UN Human Rights Office recorded the killings of 798 Palestinian civilians, including children, desperate to find food at or near distribution sites and humanitarian convoys, she said.

    More than 17,000 children have reportedly been killed and 33,000 injured in Gaza since the outbreak of the war in October 2023, an average of 28 children have been killed each day, said Russell. “Consider that for a moment. A whole classroom of children killed, every day for nearly two years.”

    In Gaza, the effects of the violence perpetrated on children have been catastrophic. International law is clear: all parties to the conflict must protect civilians and ensure the safe and unimpeded delivery of humanitarian assistance, she said while also calling for unimpeded humanitarian access and a ceasefire, as well as efforts to put an end to the war. 

    MIL OSI China News –

  • MIL-OSI USA: Video Release: Sen. Johnson Holds Hearing Entitled “Voices of the Vaccine Injured”

    US Senate News:

    Source: United States Senator for Wisconsin Ron Johnson
    WASHINGTON – Yesterday, U.S. Sen. Ron Johnson (R-Wis.), Chairman of the Permanent Subcommittee on Investigations, held a hearing entitled “Voices of the Vaccine Injured.” The Subcommittee heard from five witnesses who discussed vaccine injuries and two witnesses who discussed vaccine efficacy.
    “All of the witnesses presented powerful testimony and engaged in respectful discussion. I believe all of these stories needed to be told and listened to. I sincerely hope that the hearing helped to bridge the gap and demonstrate how to heal and unify our horribly divided nation,” Sen. Johnson said. 
    Clips of the witnesses’ testimonies can be found here. 
    Watch the full hearing here. 

    MIL OSI USA News –

  • MIL-OSI China: Eyeing China opportunities, multinational giants seek closer supply chain collaboration with Chinese partners

    Source: People’s Republic of China – State Council News

    Eyeing China opportunities, multinational giants seek closer supply chain collaboration with Chinese partners

    BEIJING, July 16 — As the third China International Supply Chain Expo opened Wednesday in Beijing, multinational companies are looking to strengthen supply chain collaborations in a move that will inject more certainty into the world economy.

    The five-day event has attracted 651 companies and institutions from 75 countries and regions. Overseas exhibitors account for 35 percent, a three-percentage-point increase from last year. Among the first-time multinational participants are major players such as Nvidia, Schneider Electric, L’Oreal, Louis Dreyfus and Medtronic.

    The growth in global participation highlights mounting confidence in the Chinese market and supply chain. The participating companies see China as both a stabilizing force and an innovation driver in the global supply chain.

    “The expo is an important gathering for innovation and collaboration, helping to strengthen the sustainable development of global manufacturing and international supply chains,” said Mohamed Kande, global chairman of PwC.

    CLOSER COLLABORATION

    The expo comes on the heels of China’s announcement of a 5.3 percent economic growth for the first half of the year despite rising challenges and external uncertainties.

    China’s steady economic growth, coupled with its robust supply chain and commitment to further opening up, positions it as a key partner for multinational companies.

    Jensen Huang, CEO of U.S. tech giant Nvidia, on Tuesday praised China’s rapid advancements in artificial intelligence (AI) during his visit to Beijing, describing the Chinese market as both “large” and “dynamic.”

    While speaking at the opening ceremony of the expo on Wednesday, Huang lauded China’s supply chain as a “miracle.” China’s open-source AI is a catalyst for global progress, giving every country and industry a chance to join the AI revolution, he said.

    “China is a very important country where the development of AI will continue to be very fast and we hope to be part of that,” Huang told reporters on Wednesday, adding that there’s so much opportunity and confidence in the Chinese market.

    Huang confirmed on Tuesday that Nvidia’s H20 chips will soon be available in the Chinese market again, following the U.S. government’s approval of the company’s filing licenses for shipping H20s to China.

    The expo has become a key venue for global firms to forge and expand supply chain collaborations.

    The expo serves as a platform for expanding McDonald’s supply chain partnerships, Xu Jansen, head of Impact Strategy at M (China) Co., Ltd. The fast food chain attended the expo for a second straight year, teaming up with 11 suppliers this year.

    Xu emphasized the importance of the Chinese market, noting that half of the 2,000 new McDonald’s stores opening each year globally are located here.

    The company has built a network of local suppliers and also helped many of them ship products overseas. China serves as a stabilizer to the global supply chain and global economic growth, Xu said in an interview.

    For French pharmaceutical giant Sanofi, the expo is also an opportunity to showcase its ecosystem and build collaborations.

    “Here, we explore innovative collaborations with our global partners, from R&D to production and patient accessibility enhancement, and share the latest results of localized practices,” said Wayne Shi, president of Sanofi Greater China. Sanofi will continue to support the Healthy China initiative with innovative drugs and vaccines, Shi said.

    RESILIENCE

    Business executives and experts assert that, given the current global economic climate, no single country can fulfill every role in industrial and supply chains. It is essential for countries to work together to achieve win-win results.

    Global firms view China as a pivotal destination for enhancing and diversifying their supply chains, owing to the country’s vast manufacturing capacity, robust industrial ecosystem, and improving business environment.

    Xiao Song, chairman, president and CEO of Siemens China, said that at a time when the global industrial landscape is undergoing rapid restructuring, the expo is becoming an important platform to promote the deep integration of all sections of the industrial chain.

    Siemens aims to help Chinese firms upgrade with digital and low-carbon technologies, helping build a green competitive edge globally as well as a more resilient and sustainable global industrial and supply chains, Xiao said.

    As the world’s first national-level exhibition focusing on supply chains, the expo is an internationally shared public product. First held in 2023, the expo has contributed to building more secure, stable, open and inclusive global industrial and supply chains.

    With over 70 special events and new alliances for exhibitors in each of the six supply chains showcased at the expo, the expo helps enterprises find partners, application scenarios and solutions, according to Ren Hongbin, chairman of the China Council for the Promotion of International Trade, the event’s organizer.

    Ren called on global business leaders to work together to uphold the multilateral trade system with the World Trade Organization at its core.

    Xu Jiabin, a professor at the Business School of Renmin University of China, said that as a manufacturing and trading powerhouse, China has made significant contributions to the stability and resilience of the global supply chain.

    “The expo will help mitigate the negative effects of trade barriers and safeguard the global international economic and trade order,” Xu said.

    MIL OSI China News –

  • MIL-OSI United Nations: Killing of Civilians in Gaza Waiting in Line for Humanitarian Aid Must End, Relief Chief Tells Security Council, Urging Return to UN-Led Delivery Mechanism

    Source: United Nations General Assembly and Security Council

    As civilians lining up for humanitarian aid in Gaza are being killed, speakers in the Security Council today urged Israel to lift restrictions on aid operations in the Strip, called for a return to United Nations-led delivery mechanisms, and stressed the urgent need for both the release of hostages and a ceasefire.

    “Gaza’s soaring humanitarian needs must be met without drawing people into a firing line,” said Tom Fletcher, Under-Secretary-General for Humanitarian Affairs and Emergency Relief Coordinator.  He recalled General Assembly resolution 46/182, adopted in 1991, which laid the groundwork for modern international humanitarian assistance by establishing a framework and guiding principles — humanity, impartiality, neutrality, and independence — for the UN’s role in coordinating humanitarian efforts during emergencies. 

    Israel, as the occupying Power, is obligated to ensure that people have food and medical supplies, he said, adding:  “But that is not happening.  Instead, civilians are exposed to death and injury, forcible displacement, stripped of dignity.”  He went on to urge Council members to consider whether Israel’s rules of engagement incorporate all feasible precautions to avoid and minimize civilian harm, in all circumstances.  This means verifying targets, giving effective advance warnings, carefully choosing tactics and weapons, and canceling or suspending an attack if it would cause disproportionate civilian harm, he said.

    Number of Aid Trucks Currently Allowed into Gaza ‘Drop in the Ocean’ 

    Between 19 May and 14 July, only 1,633 trucks — or 62 per cent of the roughly 2,600 submitted to the Israeli authorities and 74 per cent of those approved for entry — reached the Kerem Shalom and Zikim crossings.  “To be clear, this is a drop in the ocean of needs, compared to the average of 630 truckloads, that entered daily” during an earlier ceasefire, he said. The ceasefire proved what’s possible.  It’s time to return to those levels without delay.

    Turning to recent remarks by Israel’s Defence Minister about moving Palestinians into a “humanitarian city”, he said the proposal to forcibly displace Palestinians to a designated zone near Rafah is “not humanitarian”, underscoring the need to protect civilians wherever they are, release all hostages held by Hamas, allow humanitarian aid at scale and ensure the safety of humanitarian workers.  “You owe that to Israeli and Palestinian civilians, to the last hopes of a sustainable peace, and to the UN Charter,” he said, calling for a ceasefire.

    Today’s meeting was called by Denmark, France, Greece, Slovenia and the United Kingdom, following abhorrent reports of human suffering in the Occupied Palestinian Territory, including killings at aid distribution sites operated by the Gaza Humanitarian Foundation — a non-UN mechanism established with support from Israel and the United States.  Between 27 May and 7 July, the Office of the United Nations High Commissioner for Human Rights (OHCHR) recorded the killings of 798 Palestinian civilians — including children — desperate to find food, at or near distribution sites and humanitarian convoys.

    International Community Failing Gaza’s Children

    “Among the survivors was Donia, a mother seeking a lifeline for her family after months of desperation and hunger,” said Catherine Russell, Executive Director of the United Nations Children’s Fund (UNICEF).  Donia’s 1-year-old son, Mohammed, was killed in the attack after speaking his first words just hours earlier.  The mother was lying critically injured in a hospital bed, clutching her son’s tiny shoe. “No parent should experience such a horrific tragedy,” she said.

    “The simple truth is that we are failing Gaza’s children,” she said, noting that child malnutrition in Gaza has surged 180 per cent since February, with nearly 6,000 cases in June.  Most households lack safe water, fueling disease outbreaks — waterborne illnesses now make up 44 per cent of medical consultations.  Hospitals are overwhelmed, short on medicine and fuel, and emergency care is collapsing.  At least 12,500 patients, including many children, need urgent medical evacuation, but few are being accepted abroad.  “History will judge this failure harshly,” she warned, adding:  “And the children will judge it too.” 

    She implored that UNICEF and its humanitarian partners be allowed to do their jobs.  “We have proven that essentials like medicine, vaccines, water, food, and nutrition for babies can reach those in need, wherever they are, when we have appropriate access,” she said, calling for an urgent return to the functioning UN-led aid pipeline with safe and sustained humanitarian access through all available crossings.

    […]

    MIL OSI United Nations News –

  • MIL-OSI USA: Tuberville Introduces Dr. Brian Christine of Mountain Brook in Senate HELP Hearing

    US Senate News:

    Source: United States Senator Tommy Tuberville (Alabama)

    WASHINGTON – Today, U.S. Senator Tommy Tuberville (R-AL) introduced Dr. Brian Christine during his nomination hearing before the Senate Health, Education, Labor, and Pensions Committee (HELP). President Trump nominated Dr. Christine of Mountain Brook, Alabama to be Assistant Secretary for Health at the Department of Health and Human Services (HHS). During their exchange, Sen. Tuberville and Dr. Christine discussed the importance of the Make America Health Again movement, along with Dr. Christine’s goals for improving rural healthcare.

    Read excerpts from their exchange below or on YouTube or Rumble.

    TUBERVILLE: “Thank you very much. It’s an honor to introduce my friend and constituent, Dr. Brian Christine. Also thrilled to welcome today his wife, Helena, and sister, Kathleen. Thank you for being here.

    Dr. Christine is a board-certified urologic surgeon with nearly 30 years of clinical experience serving patients in Birmingham, Alabama. A recognized medical expert, Dr. Christine is known for teaching and demonstrating advanced surgical techniques, both nationally and internationally. Born in West Germany to a decorated U.S. Army combat veteran and the grandson of Italian immigrants, he will bring a lifelong dedication to service, resilience, and American values to this role. Dr. Christine attended college in Georgia, what’s going on here? And earned his medical degree from Emory University. He later moved to Birmingham for his residency and has since dedicated his career to caring for the men and women of Alabama. Beyond the operating room, he has supported local law enforcement by volunteering as a trauma surgeon with tactical police units. If confirmed, Dr. Christine will oversee critical public health programs, regional health offices and U.S. Public Health Service Commissioned Corps where he has pledged to accept a commission and lead with a Main Street medicine approach. 

    His top priorities include addressing chronic disease such as diabetes, hypertension, pediatric obesity, mental health, and the nation’s physician shortage crisis. He is particularly focused on expanding access to primary care and improving health in rural and underserved communities.

    With deep medical expertise, leadership experience, and a clear vision for reform, he is well equipped to serve as Assistant Secretary for Health, and I hope my federal colleagues will support his nomination – Dr. Christine.”

    DR. CHRISTINE: “Senator Tuberville, thank you so much for your kind words. Thank you also for the service that you’ve rendered to our nation here in the U.S. Senate and the service you have and will render to our home state of Alabama.”

    TUBERVILLE: “Thank you, Mr. Chairman. Dr. Christine, in my lifetime, I’ve never seen the deterioration of an institution like we have in the trust of the American people after COVID. How are you gonna try to put that back together? Because we desperately need some help in getting a positive attitude towards our hospitals and our doctors back to the American people.”

    DR. CHRISTINE: “Yes, Senator Tuberville, number one, thank you so much for being here. Again, thank you for your introduction. Thank you for meeting with me before today’s hearing. I’m truly appreciative. The loss of trust that we have seen in our healthcare institutions and the healthcare policies emanating from this city are the worst that I’ve seen in over three decades of practice. People feel that during the pandemic particularly they were led astray, some people feel they were lied to. We have to work to restore that trust. Secretary Kennedy is 100% committed to doing that, as is President Trump.

    In my career as a surgeon, I’ve had to earn the trust of my patients, allowing me to operate on them, literally take their life within my hands. I believe I have the ability to communicate to patients and now hopefully to the American public at large and approach them and give them a sense that what I’m saying, what I’m telling is truly for the good of the country [and] comes from a position of honesty and transparency. I’ve had to do that for over 30 years as a surgeon and as a physician. I truly believe I can bring that skillset to the office of the Assistant Secretary for Health.”

    TUBERVILLE: “Yeah. The American people are tired of being lied to about their food, the ingredients, things that we’re now finding out that are detrimental to our health. And up here, you know, we seem to overlook all that, but we need to start looking out for the American people. How do you plan to help the Secretary with that?”

    DR. CHRISTINE: “Well, we know that Secretary Kennedy is absolutely committed to the Make America Healthy Again agenda to remove toxins from our foods, to make sure that all have access to clean water, that we focus on not just treating chronic disease, but finding out what causes chronic disease, diabetes, hypertension, obesity, and work to not only cure those diseases, but really prevent and eliminate those diseases. Secretary Kennedy is always wanting to approach things from the foundation of science. He truly believes in that. I agree with the Secretary on all of those things. I intend to support him. I intend to work diligently if I have the privilege of being confirmed. To support him in that quest to make Americans healthier than they’ve ever been.” […]

    TUBERVILLE: “Dr. Christine, rural America. We got problems getting healthcare. Our state is 60% rural in Alabama. Most of the south is rural. How do we handle that problem?”

    DR. CHRISTINE: “Yes, Senator. [I think] one of the things you’re speaking about are healthcare deserts – those areas where men, women and their children don’t have ready access to primary care services such as pediatrics or gynecologic services or family practice. We have to find ways to bridge those gaps. I think that absolutely telehealth can help provide a bridge to these individuals. We’ll see what AI brings in the future. But again, technology can help bridge this gap. We absolutely must encourage and must increase the number of primary care physicians, family practitioners, pediatricians, gynecologists and opticians and primary care nurses […] to help bridge this gap as well. Now that takes a while to spin that up. But in the interim, we have to find ways to bridge the gaps. We do have to use technology. I believe that I, as Assistant Secretary for Health, one of the things that I intend to do, if I’m privileged to be in that position, will be to be a true evangelist to really go out and encourage young men and women who are in medical school and nursing school to serve in these areas. Young men and women getting into healthcare, they want a mission. Wanna help them understand that that mission to serve our brothers and sisters in rural America and healthcare deserts is truly noble and is worthwhile.”

    TUBERVILLE: “And one thing we need to sell to in rural hospitals is loyalty to the people in these communities to go to these rural hospitals so we can save them. It’s not just that they’re not being served. It’s just we have to have loyalty in those areas. Thank you.”

    Senator Tommy Tuberville represents Alabama in the United States Senate and is a member of the Senate Armed Services, Agriculture, Veterans’ Affairs, HELP and Aging Committees.

    MIL OSI USA News –

  • MIL-OSI USA: FDA to Revoke 52 Obsolete Standards of Identity for Food Products

    Source: US Department of Health and Human Services – 3

    For Immediate Release:
    July 16, 2025

    The U.S. Food and Drug Administration today announced it is revoking, or proposing to revoke, 52 food standards after concluding they are obsolete and unnecessary. The 52 standards are for canned fruits and vegetables, dairy products, baked goods, macaroni products and other foods.
    Today’s actions are the first results from the agency’s ongoing analysis of its portfolio of over 250 food Standards of Identity (SOI) to make sure they are useful, relevant and serve consumers in the best possible way. The removal of these standards is in alignment with broader efforts to ensure that HHS is directing resources to where they’re most needed – delivering better outcomes for the American people.
    “I’m eliminating outdated food regulations that no longer serve the interests of American families,” said HHS Secretary Robert F. Kennedy Jr. “Today marks a crucial step in my drive to cut through bureaucratic red tape, increase transparency and remove regulations that have outlived their purpose.”
    The FDA began establishing food standards in 1939 to promote “honesty and fair dealing” and to ensure that the characteristics, ingredients and production processes of specific foods were consistent with what consumers expect. However, advances in food science, agriculture and production practices, and additional consumer protections have made many of these older, rigid “recipe standards” unnecessary.
    “The FDA’s Standards of Identity efforts have helped ensure uniformity, boost consumer confidence and prevent food fraud. But many of these standards have outlived their usefulness and may even stifle innovation in making food easier to produce or providing consumers healthier choices,” said FDA Commissioner Marty Makary, M.D., M.P.H. “Antiquated food standards are no longer serving to protect consumers. It is common sense to revoke them and move to a more judicious use of food standards and agency resources.”
    Today’s actions include publication of the following:

    A direct final rule revoking standards for 11 types of canned fruits and vegetables that are no longer sold in U.S. grocery stores, including seven standards for fruits artificially sweetened with saccharin or sodium saccharin. The agency is issuing a companion proposed rule in the same issue of the Federal Register in case the direct final rule is withdrawn because significant adverse comments are received, and the agency needs to move forward with a proposed rule to put these changes in place.
    A proposed rule that would revoke standards for 18 types of dairy products – including certain milk and cream products, cheeses and related cheese products and frozen desserts.
    A proposed rule that would revoke standards for 23 types of food products –including bakery products, macaroni and noodle products, canned fruit juices, fish and shellfish, and food dressings and flavorings.

    Many of the standards listed in the two proposed rules predate more recent consumer protections such as requirements about ingredient safety, ingredient labeling, food packaging, safe food production and manufacturing practices and nutrition labeling information and claims.
    On May 13, HHS and FDA issued a Request for Information to identify and eliminate outdated or unnecessary regulations. This initiative supports a broader federal effort to reduce regulatory burdens and increase transparency, in alignment with President Trump’s Executive Order 14192 “Unleashing Prosperity Through Deregulation.”
    Related Information

    Related Information

    ###

    Boilerplate

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.

    Content current as of:
    07/16/2025

    Regulated Product(s)

    Follow FDA

    MIL OSI USA News –

  • MIL-OSI United Kingdom: The Africa Debate: Foreign Secretary speech

    Source: United Kingdom – Executive Government & Departments

    Speech

    The Africa Debate: Foreign Secretary speech

    The Foreign Secretary gave a speech at The Africa Debate on 2 July 2025.

    Ladies and Gentleman, Friends.

    It’s a great, great pleasure to be here today. Thank you to Sumaila and the team behind the Africa Debate, for bringing us all together.

    This week, it’s 25 years since I was first elected the Member of Parliament for Tottenham and therefore began my journey in public life. So I want to start by looking back for just a moment in time.

    I was a Member of Parliament and then a Junior Minister in the governments of Tony Blair and Gordon Brown. And they were both very, very focused on Africa and the continent of Africa.

    However, when I look back on that period, it was most definitely  principally through the lens of development and aid. This was the era of the Jubilee debt campaign. It was absolutely the era of the Millennium Development Goals. Make Poverty History was the theme of the day and the G8 Summit in Gleneagles in 2005, implementing many of the recommendations of Blair’s Commission for Africa.

    These efforts left of course a legacy. In 2000, almost two-thirds of all sub-Saharan Africans lived on under three dollars a day, by 2010, when Gordon Brown left office, the figure was under half.

    But when I became Foreign Secretary last year, I wanted to modernise our approach to Africa, modernise our approach to development.

    I of course had been travelling to the continent for many, many years, the first country I ever visited was Kenya. But I’d seen the transformation of cities and communities, all brimming with huge potential.

    And I suppose I also benefited from my own heritage in the Global South. My parents hailed from Guyana. And so I understood some of the frustrations of countries and communities when it felt like the West was ignoring people or not listening to people, not understanding what they really needed.

    I wanted to change that. And to reset relations then with the Global South, and particularly with Africa. And to implement a new approach, partnership, not paternalism.

    Genuine partnership is, by definition, between two equals each respecting the other. So in this job, I have tried to show that respect. And in the past year, I have visited eight African countries. The first Foreign Secretary to visit South Africa or Morocco since William Hague. And the first Foreign Secretary ever to visit the great country of Chad.

    And on my first visit to the continent as Foreign Secretary, I launched consultations on our new Africa Approach. A five-month listening exercise, hearing from governments, from civil society and diaspora communities, from businesses and universities, from Cape Town to Cairo, from Dakar to Djibouti, what they valued, what they wanted to see from Britain.

    We needed to listen. And I thank you all for your engagement over the course of this process and for what you told us, what we needed to hear.

    The message actually didn’t surprise me. Because what African people want from Britain is exactly what British people want from Africa. You want, we want, growth.

    And not just any form of growth, a jump in numbers on a spreadsheet for a year or two.

    But a secure, sustainable growth for everyone, high-quality jobs, affordable prices, citizens living better lives than those of their ancestors.

    You want, we want, opportunity.

    Opportunity arising from our respective strengths, like the British education system, like of course the City of London, the incredible natural assets and energised young people across Africa, and our collective commitment to multilateralism.

    And you want, and we want partnerships. Partnerships that harness our deep historic ties, and the array of personal connections that exist between us.

    But partnerships that also continue to grow and deepen, as we both invest in them. That’s just a snapshot of a detailed piece of work.

    But of course, the work can only be beginning. The real test of our Africa Approach, and this was clear in the consultation as well, is how we put it into practice.

    Because talk is cheap. It’s actions in the end that count. I am excited by the deals driving growth that we have been delivering so far.

    A new Strategic Partnership with Nigeria, a new growth plan with South Africa, a new partnership with Morocco, joint work on a new AI strategy in Ghana, and new investments in Tanzania and of course in Kenya, announced in the first East Africa Trade and Investment Forum here in London in May.

    And thanks to our Developing Countries Trading Scheme, and free trade agreements with many African countries, almost £15 billion of goods were exported from Africa to Britain tariff-free last year.

    And following the publication of the British Government’s new Trade Strategy, we will further simplify the rules of the DCTS scheme which benefits thirty-eight African countries, and review our tariffs with South Africa, Egypt, Morocco and Tunisia.

    The Trade Strategy reinforces Britain’s belief in the power of free trade. And the largest free trade area in the world is Africa’s.

    And that’s why we back the rollout of the African Continent Free Trade Agreement, reducing barriers to intra-African trade through support in areas like digital trade and custom cooperation.

    And we will increase opportunities for British firms to play their part, just as it will increase prosperity in Africa. The British businesses and investors in this room have a big part to play. And I want our Ambassadors, our High Commissioners working closely with you, so that together, we can play a confident role in investing more, and supporting the growth of the African market.

    So, more trade, more investment, this is the best path to prosperity for all.

    And there is a role of course for development as well. But this has to be a modernised approach to development, recognising that fundamentally development is about growth, development is about jobs, development is about business.

    The modern development expert needs to have a mindset of an investor, not a donor. Looking for the best return, not offering the biggest handout.

    And it’s in that spirit that British International Investment recently signed an MoU with South Africa’s Public Investment Corporation, one of Africa’s largest asset managers.

    And this week agreed to support Wave Money Mobile, an exciting African fintech unicorn.

    And it’s also in that spirit that Britain is co-hosting the next Global Fund replenishment summit in South Africa.

    And just last week I made a £1.25 billion pledge to the recent Gavi replenishment in Brussels, the largest of any sovereign donor.

    That work will save lives – many, many millions. But it will also unlock economic value -every pound given to Gavi drives £54 in wider economic benefit.

    And, crucially, it unlocks value in Britain and Africa. Gavi works closely with cutting-edge British pharmaceutical firms like GSK. And it’s also designed the first African Vaccine Manufacturing Accelerator, which is using industry partnerships to deliver vaccines for Africa.

    Vaccines, and this is very important, because people talked about that during the COVID pandemic, they asked the question, why, why are we failing, the West failing to vaccinate the African continent, and that was an important question.

    But there was a second question – why has the African continent not got its own manufacturing capability, and that is what we now need to deliver in Africa.

    Working with partners like Nigeria, we are pushing for organisations like Gavi and the Global Fund to work together and reform, so that their work has national ownership at its heart.

    National ownership is similarly important when it comes to reforming wider international finance, especially for climate and nature.

    And thank you, President Ruto, for your leadership on the climate issue particularly. The theme of your conference is precisely the right framing, Africa has Natural Capital. But it cannot unlock this if we make it impossibly challenging for states to access the finance that they need.

    At the recent Development Finance Summit in Seville, we were again pushing for reforms of the multilateral development banks and the IMF. We have to mobilise private capital and use guarantees to unlock more funds.

    To empower regional development banks, like the African Development Bank, where developing countries have more of a voice. To tackle unsustainable debt. To work with the City to bring innovations like disaster risk insurance and strengthen local capital markets.

    One example of what this can mean comes from Sierra Leone, where I can announce £2 million pounds worth of British government investment to back a mangrove restoration project by West Africa Blue. The project protects over 90,000 hectares of mangrove estuaries, improving coastal and community resilience.

    But it is also demonstrating how this model can be commercially viable, unlocking future investment in similar projects in the future. And finally, alongside our work on trade, on investment and development finance, we have heard the clear message from the consultation on illicit finance as well.

    I know that this message is not new. For years, friends in Africa have been saying Britain needs to do more to tackle dirty money. Kleptocrats and money launderers rob all our citizens of wealth and security.

    And now, the Government is listening too. That’s why I’ve started imposing sanctions on crooks who siphon off public money for themselves, like Isabel dos Santos of Angola and Kamlesh Pattni’s illicit gold smuggling network.

    And that’s why I’ve also announced that London will be hosting a Countering Illicit Finance Summit, bringing together a broad range and a broad coalition from the Global North and the Global South, to drive these criminals out of our economies.

    Friends, I said the messages of our recent consultations were that Africa wanted more growth, Africa wanted more opportunities, Africa wanted more partnerships.

    In effect, Africa wants Britain to help them to have more choices. Choices over who to do business with, because it’s choices which matter in a volatile geopolitical age.

    Britain wants choices too. And I believe that, given the choice, more and more British businesses and investors will be choosing Africa in the coming years.

    But don’t take my word for it – let’s hear from an African voice. It’s my pleasure now to introduce to the stage a great partner of the UK, a global leader on climate and nature action, and our next keynote speaker, His Excellency, Dr William Ruto, President of the Republic of Kenya.

    Updates to this page

    Published 16 July 2025

    MIL OSI United Kingdom –

  • MIL-OSI USA: Senators King, Collins, Smith Introduce Bill to Combat Lyme and Other Tick-Borne Diseases

    US Senate News:

    Source: United States Senator for Maine Angus King

    WASHINGTON, D.C. — U.S. Senators Susan Collins (R-ME) and Tina Smith (D-MN) today introduced legislation to reauthorize the Kay Hagan Tick Act, their landmark legislation to improve research, prevention, diagnostics, and treatment for tick-borne diseases, which became law in 2019. Senator Angus King (I-ME) joins them as an original co-sponsor. The Kay Hagan Tick Act unites the effort to confront the alarming public health threat posed by Lyme disease and other tick-borne diseases. Confirmed cases of Lyme disease reached a record number in Maine – 3,035 – last year. Senators Collins and Smith named their bill in honor of former Senator Kay Hagan (D-NC) who passed away on October 28th, 2019, due to complications from the tick-borne disease known as the Powassan virus.

    “Our state has been battling diseases like Lyme for decades, so it is critical we continue to invest in our research and understanding of these vector-borne diseases to better protect Maine residents and visitors,” said Senator King. “The Kay Hagan Tick Act will further the prevention efforts that keep us safe by funding research, testing and diagnostics along with resources for improved data collection. I am proud to work on this critical bipartisan legislation that will help mitigate this long-term public health threat for the future safety and health of all Maine people.”

    “Last year, Maine reported over 3,000 cases of Lyme disease—a record in our state. The reauthorization of our Tick Act is urgently needed to continue to support those who struggle with Lyme and other tick-borne illnesses and keep improving research, diagnostics, treatment, and prevention for these terrible diseases,” said Senator Collins. “Resources from the Tick Act have led to exciting developments such as the first-ever clinical trial for a Lyme disease vaccine for people, which is underway right now at the MaineHealth Institute for Research.”

    “My home state of Minnesota is proud to have more than 10,000 lakes and thousands of rivers for us to enjoy, and we’re always especially eager to get outside after a long winter,” said Senator Smith. “Unfortunately, the number of Lyme disease cases in the state—and states across the country—is on the rise. This bill would empower regional centers to lead the response against these diseases and expanded the federal government’s role in researching, testing and treating these diseases. For the sake of Americans’ health and well-being, we need to keep moving this bill forward.”

    “Reauthorizing the Kay Hagan Tick Act will continue the nation’s coordinated framework for tick-borne disease surveillance, diagnostics, and prevention”, said Griffin Dill, Director of the University of Maine Tick Lab. Continued support means earlier detection, targeted interventions, and fewer families facing the physical and financial burden of Lyme disease and other emerging infections. Through this investment, Congress can ensure a proactive approach to safeguarding our communities from increasing threats related to ticks.”

    “With an estimated 500,000 new cases of Lyme disease each year, it is critical that the United States is equipped to effectively prevent, detect, and respond to this growing public health threat,” said Bonnie Crater, co-founder and board member at Center for Lyme Action. “We applaud the foundation laid by the Kay Hagan Tick Act, which established the National Public Health Strategy to Prevent and Control Vector-Borne Diseases in Humans and we are committed to working with Congress and federal agencies to ensure this strategy is fully implemented and strengthened.  We commend Senator Collins, Senator King, and Senator Smith for their bipartisan leadership in advancing the reauthorization of this vital legislation to protect the health and safety of Americans nationwide.”

    Using a three-pronged approach, the Kay Hagan Tick Reauthorization Act would:

    1. Require the Department of Health and Human Services (HHS) to continue implementing and updating, as appropriate, its National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People.  This strategy has been integral in expanding research into tick-borne diseases, improving testing and diagnostics, and coordinating efforts across the federal government.
    1. Reauthorize Regional Centers of Excellence in Vector-Borne Disease for five years. Funding for these centers, which was allotted in 2017, expires this year. These Centers have led the scientific response against tick-borne diseases, which now make up 75 percent of vector-borne diseases in the U.S.  There are four centers located at universities in California, Florida, Texas, and Wisconsin. 
    1. Reauthorize CDC Grants to State Health Departments to improve data collection and analysis, support early detection and diagnosis, improve treatment, and raise awareness.  These awards would help states continue to build a public health infrastructure for Lyme and other vector-borne diseases and amplify their initiatives through public-private partnerships.   

    In May, Senator Collins delivered the opening remarks at the Center for Lyme Action Congressional Series and spoke to the need for continued federal funding for tick-borne disease research. Click here to watch and here to download her remarks. Senator Collins has also urged leading health officials to continue to support the development of treatment for these illnesses, including the clinical trials currently ongoing in Maine for the first Lyme disease vaccine for people.

    Senator King is a longtime advocate for the elimination of vector-borne diseases. His SMASH Act, bipartisan legislation to reauthorize critical public health tools that support states and localities in their mosquito surveillance and control efforts, especially those linked to mosquitos that carry the Zika virus, and improve the nation’s preparedness for Zika and other mosquito-borne threats like West Nile virus, chikungunya, and Eastern Equine Encephalitis (“triple-e”) virus was signed into law in 2019. A re-authorization of SMASH was introduced in 2023 and included in the Pandemic All-Hazards Preparedness Act Reauthorization.

    MIL OSI USA News –

  • MIL-OSI Analysis: What is peer review? The role anonymous experts play in scrutinizing research before it gets published

    Source: The Conversation – USA – By Joshua Winowiecki, Assistant Professor of Nursing, Michigan State University

    Reviewer 1: “This manuscript is a timely and important contribution to the field, with clear methodology and compelling results. I recommend publication with only minor revisions.”

    Reviewer 2: “This manuscript is deeply flawed. The authors’ conclusions are not supported by data, and key literature is ignored. Major revisions are required before it can be considered.”

    These lines could be pulled from almost any editorial decision letter in the world of academic publishing, sent from a journal to a researcher. One review praises the work, while another sees nothing but problems. For scholars, this kind of contradiction is common. Reviewer 2, in particular, has become something of a meme: an anonymous figure often blamed for delays, rejections or cryptic critiques that seem to miss the point.

    But those disagreements are part of the peer-review process.

    A world of memes – like this one shared on Reddit – has sprung up about the ridiculous feedback provided by a mythical Reviewer #2.
    Reddit/r/medicalschool

    As a clinical nurse specialist, educator and scholar who reviews studies in nursing and health care and teaches others to do so critically as well, I’ve seen how peer review shapes not just what gets published, but what ultimately influences practice.

    Peer review is the checkpoint where scientific claims are validated before they are shared with the world. Researchers and scholars submit their findings to academic journals, which invite other scholars with similar expertise – those are the peers – to assess the work. Reviewers look at the way the scholar designed the project, the methods they used and whether their conclusions stand up.

    The point of peer review

    This process isn’t new. Versions of peer review have been around for centuries. But the modern form – anonymous, structured and managed by journal editors – took hold after World War II. Today, it is central to how scientific publishing works, and nowhere more so than health, nursing and medicine. Research that survives review is more likely to be trusted and acted upon by health care practitioners and their patients.

    Millions of research papers move through this process annually, and the number grows every year. The sheer volume means that peer review isn’t just quality control, it’s become a bottleneck, a filter of sorts, and a kind of collective judgment about what counts as credible.

    In clinical fields, peer review also has a protective role. Before a study about a new medication, procedure or care model gains traction, it is typically evaluated by others in the field. The point isn’t to punish the authors – it’s to slow things down just enough to critically evaluate the work, catch mistakes, question assumptions and raise red flags. The reviewer’s work doesn’t always get credit, but it often changes what ends up in print.

    So, even if you’ve never submitted a paper or read a scientific journal, peer-reviewed science still shows up in your life. It helps shape what treatments are available, what protocols and guidelines your nurse practitioner or physician uses, and what public health advice gets passed along on the news.

    This doesn’t mean peer review always works. Plenty of papers get published despite serious limitations. And some of these flawed studies do real harm. But even scholars who complain about the system often still believe in it. In one international survey of medical researchers, a clear majority said they trusted peer-reviewed science, despite frustrations with how slow or inconsistent the process can be.

    What actually happens when a paper is reviewed?

    Before a manuscript lands in the hands of reviewers, it begins with the researchers themselves. Scientists investigate a question, gather and analyze their data and write up their findings, often with a particular journal in mind that publishes new work in their discipline. Once they submit their paper to the journal, the editorial process begins.

    At this point, journal editors send it out to two or three reviewers who have relevant expertise. Reviewers read for clarity, accuracy, originality and usefulness. They offer comments about what’s missing, what needs to be explained more carefully, and whether the findings seem valid. Sometimes the feedback is collegial and helpful. Sometimes it’s not.

    Peer reviewers’ comments can help researchers revise and strengthen their work.
    AJ_Watt/E+ via Getty Images

    Here is where Reviewer 2 enters the lore of academic life. This is the critic who seems especially hard to please, who misreads the argument, or demands rewrites that would reshape the entire project. But even these kinds of reviews serve a purpose. They show how work might be received more broadly. And many times they flag weaknesses the author hadn’t seen.

    Review is slow. Most reviewers aren’t paid, with nearly 75% reporting they receive no compensation or formal recognition for their efforts. They do this work on top of their regular clinical, teaching or research responsibilities. And not every editor has the time or capacity to sort through conflicting feedback or to moderate tone. The result is a process that can feel uneven, opaque, and, at times, unfair.

    It doesn’t always catch what it is supposed to. Peer review is better at catching sloppy thinking than it is at detecting fraud. If data is fabricated or manipulated, a reviewer may not have the tools, or the time, to figure that out. In recent years, a growing number of published papers have been retracted after concerns about plagiarism or faked results. That trend has shaken confidence in the system and raised questions about what more journals should be doing before publication.

    Imperfect but indispensable

    Even though the current peer-review system has its shortcomings, most researchers would argue that science is better off than it would be without the level of scrutiny peer review provides. The challenge now is how to make peer review better.

    Some journals are experimenting with publishing reviewer comments alongside articles. Other are trying systems where feedback continues after publication. There are also proposals to use artificial intelligence to help flag inconsistencies or potential errors before human reviewers even begin.

    These efforts are promising but still in the early stages of development and adoption. For most fields, peer review remains a basic requirement for legitimacy, while some, such as law and high-energy physics, have alternate methods of communicating their findings. Peer review assures a reader that a journal article’s claim has been tested, scrutinized and revised.

    Peer review doesn’t guarantee truth. But it does invite challenge, foster transparency, offer reflection and force revision. That’s often where the real work of science begins.

    Even if Reviewer 2 still has notes.

    Joshua Winowiecki does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    – ref. What is peer review? The role anonymous experts play in scrutinizing research before it gets published – https://theconversation.com/what-is-peer-review-the-role-anonymous-experts-play-in-scrutinizing-research-before-it-gets-published-258255

    MIL OSI Analysis –

  • MIL-OSI Analysis: Measles isn’t just dangerous – it may erase your immune system

    Source: The Conversation – UK – By Antony Black, Lecturer, Life Sciences, University of Westminster

    INSAGO/Shutterstock

    Blindness, pneumonia, severe diarrhoea and even death – measles virus infections, especially in children, can have devastating consequences. Fortunately, we have a safe and effective defence. Measles vaccines are estimated to have averted more than 60 million deaths between 2000 and 2023.

    Yet despite this success, measles cases are rising sharply in the UK and around the world. This global surge is the result of several factors, from vaccine hesitancy to missed immunisation campaigns, leaving many children unprotected and vulnerable.

    But there’s more at stake than just measles itself. Emerging research suggests that the measles vaccination may offer surprising additional health benefits. Children who receive the vaccine have been shown to have a significantly lower risk of infections from diseases unrelated to measles.

    Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK’s latest coverage of news and research, from politics and business to the arts and sciences.

    One explanation for this broader benefit is the idea of “measles amnesia.” This refers to the ability of the measles virus to erase parts of the body’s immune memory.

    Our immune system contains various cells that protect us from infections. Some produce antibodies that neutralise viruses, while others detect and destroy infected cells. Immune memory allows the body to “remember” past infections and mount faster responses in the future.

    However, measles infection may reduce the number and diversity of these memory cells – leaving children vulnerable to a wide range of diseases they had previously developed immunity to. In other words, the virus doesn’t just make children ill in the short term, it may also undo years of immune protection.

    In one study, researchers found that between 11% and 73% of antibodies targeting other diseases were lost after a measles infection in unvaccinated children. This immune depletion was not observed in children who had received the vaccine, suggesting that vaccination protects against this damaging effect.

    This broad loss of immune protection may explain why measles outbreaks are often followed by spikes in other infectious diseases. Ongoing studies are exploring the impact of measles amnesia in regions such as West Africa, where measles and other infections remain widespread.

    A vaccine that does more?

    Another theory for the vaccine’s broader benefit is known as the “non-specific effect”. Unlike measles amnesia, which explains how the virus weakens immunity, the non-specific effect suggests that the measles vaccine actively strengthens the immune system against a wide range of pathogens.

    Recent research has shown that measles vaccination may enhance the function of certain immune cells, making them more effective at fighting off other diseases. Some scientists believe this effect, rather than protection against amnesia alone, could be the primary reason why vaccinated children have better overall health outcomes.

    The measles vaccine is a live attenuated vaccine, which means it uses a weakened version of the virus to stimulate a strong immune response. Live vaccines, including the BCG vaccine for tuberculosis, are known to provide broad immune training effects, which may explain this non-specific protection.

    Forgotten the dangers

    In the 1960s, before widespread vaccination, measles caused around 2.6 million deaths per year. It’s hard to imagine today, but that’s partly the problem.

    As measles became rare, society began to forget how serious it is. We forgot how contagious it is (one infected person can spread the virus to up to 90% of nearby unvaccinated people) and we forgot how effective vaccination is (two doses provide more than 90% long-term protection).

    And in some circles, this fading memory has been replaced by something more dangerous: mistrust. Misinformation, vaccine myths, and anti-vaccine rhetoric are spreading, just like the virus itself.

    So, whether the additional protection offered by the vaccine is due to prevention of immune amnesia, a non-specific immune boost, or both, the takeaway is the same: Vaccinate children against measles. Because when we protect them from measles, we may also be protecting them from so much more.

    Antony Black does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    – ref. Measles isn’t just dangerous – it may erase your immune system – https://theconversation.com/measles-isnt-just-dangerous-it-may-erase-your-immune-system-261136

    MIL OSI Analysis –

  • MIL-OSI USA: Senators Collins, Smith, King Introduce Bill to Combat Lyme and Other Tick-Borne Diseases

    US Senate News:

    Source: United States Senator for Maine Susan Collins

    Washington, D.C. — U.S. Senators Susan Collins (R-ME) and Tina Smith (D-MN) today introduced legislation to reauthorize the Kay Hagan Tick Act, their landmark legislation to improve research, prevention, diagnostics, and treatment for tick-borne diseases, which became law in 2019. Senator Angus King (I-ME) joins them as an original co-sponsor. The Kay Hagan Tick Act unites the effort to confront the alarming public health threat posed by Lyme disease and other tick-borne diseases. Confirmed cases of Lyme disease reached a record number in Maine – 3,035 – last year. Senators Collins and Smith named their bill in honor of former Senator Kay Hagan (D-NC) who passed away on October 28th, 2019, due to complications from the tick-borne disease known as the Powassan virus.

    “Last year, Maine reported over 3,000 cases of Lyme disease—a record in our state. The reauthorization of our Tick Act is urgently needed to continue to support those who struggle with Lyme and other tick-borne illnesses and keep improving research, diagnostics, treatment, and prevention for these terrible diseases,” said Senator Collins. “Resources from the Tick Act have led to exciting developments such as the first-ever clinical trial for a Lyme disease vaccine for people, which is underway right now at the MaineHealth Institute for Research.”

    “My home state of Minnesota is proud to have more than 10,000 lakes and thousands of rivers for us to enjoy, and we’re always especially eager to get outside after a long winter,” said Senator Smith. “Unfortunately, the number of Lyme disease cases in the state—and states across the country—is on the rise. This bill would empower regional centers to lead the response against these diseases and expanded the federal government’s role in researching, testing and treating these diseases. For the sake of Americans’ health and well-being, we need to keep moving this bill forward.”

    “Our state has been battling diseases like Lyme for decades, so it is critical we continue to invest in our research and understanding of these vector-borne diseases to better protect Maine residents and visitors,” said Senator King. “The Kay Hagan Tick Act will further the prevention efforts that keep us safe by funding research, testing and diagnostics along with resources for improved data collection. I am proud to work on this critical bipartisan legislation that will help mitigate this long-term public health threat for the future safety and health of all Maine people.”

    “Reauthorizing the Kay Hagan Tick Act will continue the nation’s coordinated framework for tick-borne disease surveillance, diagnostics, and prevention”, said Griffin Dill, Director of the University of Maine Tick Lab. Continued support means earlier detection, targeted interventions, and fewer families facing the physical and financial burden of Lyme disease and other emerging infections. Through this investment, Congress can ensure a proactive approach to safeguarding our communities from increasing threats related to ticks.”

    “With an estimated 500,000 new cases of Lyme disease each year, it is critical that the United States is equipped to effectively prevent, detect, and respond to this growing public health threat,” said Bonnie Crater, co-founder and board member at Center for Lyme Action. “We applaud the foundation laid by the Kay Hagan Tick Act, which established the National Public Health Strategy to Prevent and Control Vector-Borne Diseases in Humans and we are committed to working with Congress and federal agencies to ensure this strategy is fully implemented and strengthened.  We commend Senator Collins, Senator King, and Senator Smith for their bipartisan leadership in advancing the reauthorization of this vital legislation to protect the health and safety of Americans nationwide.”

    Using a three-pronged approach, the Kay Hagan Tick Reauthorization Act would:

    1. Require the Department of Health and Human Services (HHS) to continue implementing and updating, as appropriate, its National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People.  This strategy has been integral in expanding research into tick-borne diseases, improving testing and diagnostics, and coordinating efforts across the federal government.
    1. Reauthorize Regional Centers of Excellence in Vector-Borne Disease for five years. Funding for these centers, which was allotted in 2017, expires this year. These Centers have led the scientific response against tick-borne diseases, which now make up 75 percent of vector-borne diseases in the U.S.  There are four centers located at universities in California, Florida, Texas, and Wisconsin. 
    1. Reauthorize CDC Grants to State Health Departments to improve data collection and analysis, support early detection and diagnosis, improve treatment, and raise awareness.  These awards would help states continue to build a public health infrastructure for Lyme and other vector-borne diseases and amplify their initiatives through public-private partnerships.   

    In May, Senator Collins delivered the opening remarks at the Center for Lyme Action Congressional Series and spoke to the need for continued federal funding for tick-borne disease research. Click here to watch and here to download her remarks. Senator Collins has also urged leading health officials to continue to support the development of treatment for these illnesses, including the clinical trials currently ongoing in Maine for the first Lyme disease vaccine for people.

    Senator King is a longtime advocate for the elimination of vector-borne diseases. His SMASH Act, bipartisan legislation to reauthorize critical public health tools that support states and localities in their mosquito surveillance and control efforts, especially those linked to mosquitos that carry the Zika virus, and improve the nation’s preparedness for Zika and other mosquito-borne threats like West Nile virus, chikungunya, and Eastern Equine Encephalitis (“triple-e”) virus was signed into law in 2019. A re-authorization of SMASH was introduced in 2023 and included in the Pandemic All-Hazards Preparedness Act Reauthorization.

    MIL OSI USA News –

  • MIL-OSI Asia-Pac: LCQ19: Promoting efficient district governance

    Source: Hong Kong Government special administrative region – 4

    ​Following is a question by the Hon Chan Yung and a written reply by the Secretary for Home and Youth Affairs, Miss Alice Mak, in the Legislative Council today (July 16):

    Question:

         The Secretary for Home and Youth Affairs pointed out during a media interview last month that the District Councils, “the three district committees” (i.e. the Area Committees, the District Fight Crime Committees and the District Fire Safety Committees) and the District Services and Community Care Teams (Care Teams) are the troika of district governance, with clear divisions of work and high levels of collaboration. In this connection, will the Government inform this Council:

    (1) how it will continue to strengthen co-operation among the aforesaid three parties;

    (2) given that the Secretary for Home and Youth Affairs mentioned in the aforesaid interview that the scope of work of the Care Teams is under review, of the current progress of the relevant work; and

    (3) whether it will, by drawing on the district governance experiences of the Mainland and Singapore, continue to enhance support in terms of systems, policies and resources, so as to provide more care services for the communities and residents (such as establishing government centres in districts with single-window services from various government departments)?

    Reply:

    President,

         With regards to the member’s question, our reply is as follows:

    (1) Under the improved district governance system, the District Councils (DCs) play the role of complementing and supporting the Government, assisting the Government to gauge public opinions and local sentiments, implement policies and measures, and respond to public aspirations, as well as promoting community involvement activities. The “three district committees” (i.e. the Area Committees, the District Fight Crime Committees and the District Fire Safety Committees) offer advice to the Government according to their respective purviews (e.g. fire prevention, combat crime, etc), and help organise community activities. The District Services and Community Care Teams (Care Teams) are Government-led service teams working in sub-districts to provide people with a wide range of caring and support services, and assist in handling incidents and emergencies. District Officers, as DC Chairmen and Commanders of Care Teams, are responsible for leading the “troika” to collaborate with each other, achieve synergy and provide services to people in need.

    The “troika” are highly integrated. Since April 2024, the Government appointed all incumbent DC members to be members of the “three district committees” with a view to strengthening the connection and collaboration between both sides. DC members also often work with Care Teams to organise various district activities to strengthen community cohesion and allow caring services to reach the community. Each District Office has also established a mechanism to swiftly mobilise and co-ordinate members of the “troika” to assist in handling incidents and emergencies within the district. For example, for the recent drinking water incidents at Queens’ Hill Estate and Shan Lai Court, members of the North DC, members of the “three district committees” and Care Teams conducted over 1 500 home visits over a weekend, set up street booths at each key location to provide residents with the latest water information, and register residents’ requests for assistance and make referrals.

    The Home and Youth Affairs Bureau, the Home Affairs Department and District Offices will continue to enhance co-ordination of the DCs, the “three district committees”, Care Teams and other district organisations and groups to collaborate with the Government. We will also keep under review the actual operational experiences and listen to the views of different sectors to continuously improve the collaboration mechanism, so as to enhance the efficacy of district governance.

    (2) and (3) Since the full launch of 452 Care Teams in 18 districts in the third quarter of 2023, Care Teams have been actively engaging and serving residents in the sub-districts. In addition to the swift mobilisation for incidents and emergency responses as mentioned above and caring for the needs of affected individuals, Care Teams also provide caring services to residents in the districts, including visiting or contacting elderly households and other households in need (e.g. households in subdivided flats and chronic patients, etc), establishing connections with them and providing relevant service information, assisting them in applying and setting up appointments for public services. Care Teams also offer home or other support services to those in need (e.g. basic home repairs and cleansing). As at end June 2025, Care Teams have visited about 530 000 elderly households and other households in need, provided about 76 000 times of basic home or other support services, and organised about 38 000 district-level activities, such as free Chinese medicine consultations, vaccination services, mental well-being support programmes, national security and civic education activities. In terms of promoting government policies, Care Teams have been proactively assisting the Government in promoting various policies, such as distributing promotional leaflets for the Department of Health to disseminate messages about disease prevention to the public, collaborating with district Police Community Relations Office to disseminate messages relating to fraud prevention. Besides, Care Teams in 18 districts also participate in the Social Welfare Department’s District Services and Community Care Teams – Scheme on Supporting Elderly and Carers. Through visits or contact with singleton/doubleton elderly households, and carers of elderly persons and persons with disabilities, Care Teams would help identify needy cases and refer them to relevant social welfare units for follow up. They will also assist in referring eligible elderly persons and persons with disabilities to install and use emergency alarm systems.

    The first term of the service agreements for Care Teams in 18 districts will be concluding in September to October this year. With a view to improving the effectiveness of Care Teams’ work in the next term, we are reviewing various aspects of Care Teams. The Government adheres to the principle of “people-oriented and local circumstances suited” when planning and promoting work in districts. Hong Kong has a highly dense population and a diverse community structure. Each district has different demographics, geographical environments, social facilities and residents’ needs. Therefore, while we may draw reference from the governance experience of Mainland China and Singapore, we shall fully take into account the uniqueness of each district in Hong Kong and flexibly adapt the service models in accordance with local conditions and needs.

    As announced in 2024 Policy Address, the Government will regularise Care Teams, and increase funding amount by 50 per cent in the next term of service in support of their work. Building on the established district networks and the foundation of the caring works, Care Teams will continue to strengthen and further extend their services at the district level through the effective use of the additional resources in the next term of service. Looking ahead, we will continue to strengthen the collaboration mechanism among the DCs, the “three district committees” and Care Teams – the “troika” – to comprehensively enhance service effectiveness and continuously improve people’s sense of well-being and fulfilment.

    MIL OSI Asia Pacific News –

  • MIL-OSI United Nations: 16 July 2025 Departmental update WHO recommends rapid treatment initiation for people living with HIV and mpox

    Source: World Health Organisation

    In the latest update of the clinical management and infection prevention control of mpox guidelines (May 2025) WHO has issued a strong recommendation for the rapid initiation of antiretroviral therapy (ART) in people living with HIV who are diagnosed with mpox.

    Mpox disproportionally affects people living with HIV. The infection is more severe with higher rates of mortality and hospitalization in people with advanced HIV disease. 

    This recommendation aligns with WHO’s broader HIV treatment guidance that strongly recommends rapid ART initiation – ideally within seven days of HIV diagnosis, including same-day start – to reduce mortality and achieve viral suppression. While concerns about mpox immune reconstitution inflammatory syndrome (IRIS) exist, WHO experts concluded that the benefits of rapid ART initiation outweigh potential risks, especially given the lack of effective mpox-specific treatments.

    The guideline also emphasizes the importance of early HIV testing for all patients presenting with suspected or confirmed mpox. For individuals already on ART with a suppressed viral load, treatment should continue without interruption.

    “We now know people with HIV, particularly those with a CD4 count under 200 cells/mm³, are at risk for severe disease and death from mpox,” said Dr Meg Doherty, Director of WHO’s Global HIV, Hepatitis and STI Programmes. “Ensuring early access to HIV and syphilis testing and treatment to all people with confirmed or suspected mpox, as well as timely access to mpox vaccines and antivirals, will save lives”.

    This recommendation reflects WHO’s commitment to integrated care and highlights the importance of timely HIV diagnosis and treatment in mitigating severe outcomes in co-infected patients. To strengthen implementation of early testing, WHO has published standard operating procedures for integrated testing, including HIV and syphilis, as part of the mpox response.

    WHO’s diagnostic and treatment guidance provide essential information and tools to optimize health outcomes.

    MIL OSI United Nations News –

  • MIL-OSI United Kingdom: Life Sciences Sector Plan to grow economy and transform NHS

    Source: United Kingdom – Executive Government & Departments

    Press release

    Life Sciences Sector Plan to grow economy and transform NHS

    The government has today (Wednesday 16 July) launched a bold new Life Sciences Sector Plan as part of the government’s flagship Industrial Strategy.

    The government has today (Wednesday 16 July) launched a bold new Life Sciences Sector Plan as part of the government’s flagship Industrial Strategy, setting out a ten-year mission to harness British science and innovation to deliver long-term economic growth and a stronger, prevention-focused NHS.

    The UK is already a global leader in life sciences, with the sector worth around £100 billion to the economy, and employing around 300,000 people. This plan, developed in close coordination with the government’s 10 Year Health Plan, doubles down on that strength – turning cutting-edge research into real-world results: new treatments, faster diagnoses, and more lives saved. It’s about making sure breakthroughs happen here – and stay here – creating jobs, improving lives in every part of the country, and driving growth.

    Life sciences’ critical importance to both driving economic growth and improving our health – 2 of the core elements of the Plan for Change – has been shown through the government’s action to date to support the sector. The Chancellor re-committed up to £520 million for the Life Sciences Innovative Manufacturing Fund at the Spending Review to pull investment into the UK, and red tape is being slashed to speed up clinical trials, while an up to £600 million investment will deliver a Health Data Research Service that will be unmatched globally – bringing the power of data to bear to unlock breakthroughs in the diagnosis and treatment of diseases.

    The plan sets out a comprehensive roadmap built around 3 core pillars:

    1. Enabling World-Class R&D – strengthening the UK’s leadership in science and discovery
    2. Making the UK an outstanding place to start, scale and invest – growing homegrown companies and attracting global capital
    3. Driving Health Innovation and NHS Reform – delivering better outcomes for patients and a more modern, preventative healthcare system

    6 bold actions to kickstart change

    The Life Sciences Sector Plan will be supported over the lifetime of the Spending Review by government funding of over £2 billion, alongside funding from UKRI and NIHR. Actions include:

    1. Unlocking NHS data to find new cures

    Up to £600 million investment to build the world’s most advanced health data system – helping scientists develop better treatments faster.

    2. Speeding up clinical trials

    Cutting red tape so patients can join trials sooner – and get access to life-changing medicines quicker.

    3. Backing British manufacturing

    Up to £520 million to invest in life sciences manufacturing projects – creating high-skilled jobs and making more treatments and medical devices here at home.

    4. Getting new treatments to patients faster

    Making regulation simpler and faster by boosting departmental support for the MHRA with additional investment – so doctors can use safe, effective innovations without delay.

    5. Helping doctors use cutting-edge tech

    A new NHS ‘passport’ to roll out proven tools faster – like AI cancer scanners or wearable devices that detect disease early.

    6. Backing brilliant UK firms to grow

    Helping fast-growing companies raise investment, scale up, and stay in the UK – with at least one major industry partnership secured every year.

    Built for delivery

    This Plan was shaped with input from over 250 organisations including doctors, scientists, NHS leaders and industry experts to ensure it delivers real impact. It builds on the strong foundations of the 10-Year Health Plan, extending its ambition by uniting health and growth interventions into a single, coherent strategy for the Life Sciences sector. Every action has clear goals and named leads. This is a Plan designed to deliver, not in isolation but as a vital part of the government’s broader Plan for Change.

    Early momentum 

    The plan builds on the Chancellor’s commitment to reduce regulatory costs by a quarter, with increased investment in the MHRA to accelerate approvals and improve efficiency. It aims to streamline MedTech market entry through closer coordination between the MHRA and NICE.  

    The government is also focused on strengthening the UK’s clinical research infrastructure by improving trial delivery, expanding patient access, and embedding research more effectively within the NHS. 

    We have already started delivering on key actions, from investing up to £600 million in the Health Data Research Service alongside Wellcome, through to committing over £650 million in Genomics England and up to £354 million in Our Future Health, while the rollout of ‘innovator passports’ will help speed up the adoption of new tech and treatments on the NHS. This is clear evidence of our commitment and confidence in life sciences as a driver of both economic growth and better health outcomes. 

    Why life sciences matter

    • Life Sciences is one of 8 priority sectors in the government’s Industrial Strategy – reflecting the sector’s high growth potential.
    • Life sciences companies employ over 300,000 people, with more than three-quarters of jobs outside London and the Southeast, supporting opportunity in every part of the UK.
    • The sector improves economic productivity by improving health. With long-term illness a major drag on workforce participation, better health leads directly to a stronger, more resilient economy.
    • The Life sciences sector attracts record levels of private investment. In 2023, the UK raised the third highest amount of life sciences equity finance in the world, behind only the US and China.
    • It is a UK export powerhouse -medicines and medical technologies were the UK’s third largest goods export by value in 2024.
    • And it is innovation-intensive, with 17% of all UK business R&D spend is in pharmaceuticals, the highest of any sector.
    • Artificial Intelligence (AI) is also revolutionising the Life Sciences sector across research, diagnostics, treatment, and manufacturing, reshaping how we prevent, treat, and manage disease. The potential economic impact is substantial, with McKinsey Global Institute estimating that AI could generate $60–110 billion annually for the pharmaceutical and medical-product industries alone .

    Chancellor of the Exchequer, Rachel Reeves, said:

    Our world-leading life sciences sector employs hundreds of thousands of people and is a powerhouse for economic growth that puts more money in people’s pockets. Our Plan for Change is ramping up this success story even further.

    The ten-year life sciences plan we have released today as part of our Industrial Strategy will cut red tape and deliver the investment we funded at the Spending Review so it can stay ahead of the curve globally and we can reap the economic rewards for years to come.

    Science and Technology Secretary Peter Kyle said:

    The life sciences sector is one of the crown jewels of the UK economy. It sits at the heart of both our Plan for Change, and our Modern Industrial strategy, as a unique catalyst for both economic prosperity, and better health outcomes for people across the UK.

    Moving in lockstep with industry, academia and our NHS, we will unleash this sector as a force for good and for growth. The suite of measures we’re announcing today will unlock its full potential — attracting global investment, accelerating innovation, and delivering breakthroughs that will make the UK healthier, wealthier, and even more open for business.

    Business Secretary Jonathan Reynolds said:

    We’re committed to making the UK a life sciences superpower, and our modern Industrial Strategy has earmarked it as one of 8 priority sectors so it can double down on our strengths and keep us at the cutting edge of innovation.

    This government is taking the bold action needed to help this £108 billion industry flourish and create new high-skilled, well-paid jobs right across the country, making our Plan for Change a reality.

    Health Secretary Wes Streeting said:

    This Life Sciences Sector Plan represents a pivotal moment in our mission to rebuild the NHS and shift our healthcare system from one that treats illness to one that prevents it.

    By bringing together the brilliance of British science with the power of our NHS, we’re not just improving healthcare outcomes – we’re building a stronger economy and creating jobs across the country.

    The £2 billion investment will help us make the most of our world-leading health data, speed up access to innovative treatments, and transform the experience of patients. This is how we deliver a health service fit for the future – by embracing innovation that saves lives, cuts waiting times, and makes the NHS sustainable for generations to come.

    The plan comes just days on the same day as the fourth “Made in the UK, Sold to the World” Roadshow, a government-led initiative designed to boost SME exports in the Life Sciences sector.

    The roadshow focuses on the 8 sectors highlighted in the modern industrial strategy, forming part of the government’s commitment to supporting high-growth industries with the greatest potential to create jobs, increase productivity, and drive long-term economic growth.

    Support for the Life Sciences Sector Plan

    Professor Sir John Bell, President of the Ellison Institute of Technology and UK Government Life Sciences Champion said: 

    With our world-leading science base, genomics capabilities and industrial heritage, our Life Sciences sector can truly be among the best globally, ensuring the UK is developing and benefiting from the technologies of the future. We must however move past high level ambitions. This plan, with an inbuilt, relentless focus on delivery, provides the vehicle to take us there.

    Deepak Nath, CEO of Smith+Nephew, said:  

    Smith+Nephew welcomes the publication of the government’s Life Sciences Sector Plan and its clear recognition of the critical role that medical technology plays in building a sustainable, high-performing NHS.  

    We are encouraged by the plan’s focus on the full life cycle of medical technologies – from research and development, and manufacturing, through to regulation, evaluation and adoption – and by the continued engagement with industry throughout its development.  We look forward to supporting the plan’s implementation.

    Dr Tony Wood, Chief Scientific Officer, GSK, said: 

    We welcome the government’s Life Sciences Sector Plan – in particular, the reforms to incentivise more UK clinical trials, establish a new Health Data Research Service and create a network of translational labs and clinics to accelerate drug discovery and development. These changes can bring unique competitive advantage to the country and make the UK a leader in future life sciences research.

    Tim Sheppard, SVP & GM, North Europe, IQVIA, said:

    IQVIA welcomes the Life Sciences Sector Plan and its bold ambition to realise  more investment in commercial R&D than any other country in Europe by 2030.

    Human data science and AI technology underpin our global leadership in commercial clinical research, we recognise the potential in the Plan for the Health Data Research Service to be a catalyst in the UK Government’s  commitment to create the  world’s most advanced and secure health data platform, enhancing the UK’s attractiveness for global trials and AI investment.

    The Life Sciences Sector Plan will strengthen IQVIA’s ability to offer its global life sciences sponsors a seamless and efficient development pathway from early phase trials to regulatory approval and enhance patient access to innovative treatments – improving patients’ lives and driving further economic growth in the UK.

    Steve Rotheram, Mayor of the Liverpool City Region, said: 

    The Liverpool City Region has a proud history of innovation and is fast becoming recognised as a powerhouse in health and life sciences – from pioneering infection and disease control to cutting-edge manufacturing.  

    This plan is a welcome step towards unlocking the sector’s full potential, and I’m confident our region will play a central role in delivering that ambition. With our world-leading assets in biomanufacturing, digital health and infectious disease research, we’re already demonstrating how innovation in our region can improve lives, create highly skilled jobs, and attract global investment. Backed by the right partnerships and investment, we can help cement the UK’s place as a global leader in life sciences.

    Lord Ara Darzi, Paul Hamlyn Chair of Surgery, Imperial College London, Consultant Surgeon, Imperial College Healthcare NHS Trust and the Royal Marsden NHS Foundation Trust and Independent Member of the House of Lords said: 

    This plan is a detailed blueprint for implementation. It marks a profound change not just in how we go about enabling discovery but also in the way we deliver it. It sets the United Kingdom up to lead not just in trialling innovation but in making such innovations have real world impact for the benefit for patients, the National Health Service, and economic growth.

    Dr. Vin Diwakar, Clinical Transformation Director at NHS England, said:

    The Life Sciences Sector Plan is a major step forward, accelerating patient access to the latest health innovations through better industry partnerships, solidifying the NHS’s role in economic growth. Through initiatives like the Health Data Research Service and ‘innovator passports,’ we’re unlocking data’s potential for cures and fast-tracking proven health technologies, ultimately transforming patient care and making the NHS fit for the future.

    Peter Ellingworth, Chief Executive of the Association of British HealthTech Industries (ABHI) said:  

    ABHI welcomes the publication of the Life Sciences Sector Plan. Developed with meaningful engagement from the HealthTech industry, it recognises the critical role that HealthTech will play in driving innovation and supporting the NHS to deliver the reforms needed to ensure its long-term sustainability. We are particularly encouraged by the commitments to regulatory reform, investment in research infrastructure, and measures to accelerate the adoption of innovation. To succeed, this strategy must be delivered in genuine partnership with industry and the NHS, and focused on removing the persistent barriers that prevent patients from benefiting from the best technologies. ABHI and our members are committed to playing an active role in translating these ambitions into tangible improvements for patients, the NHS and the economy.

    Paul Tredwell, Executive Vice President of Accord Healthcare said: 

    It is very encouraging to see a Life Sciences Sector Plan which for the first time recognises the immense contribution of the off-patent industry, a sector which provides around 80% of all the UK’s medicines. As one of the largest manufacturers supplying medicines to the NHS, and a company currently applying to the government’s LSIMF scheme, we welcome this Sector Plan as a positive step and look forward to working with government on policies that will support future growth and investment.

    Nicola Perrin MBE, Chief Executive of the Association of Medical Research Charities (AMRC) said: 

    We’re pleased to see life sciences recognised as a priority sector for the UK. This is a triple win for the economy, for the NHS and for patients. It will benefit people across the country and unlock new ways to prevent, diagnose and treat disease. 

    We welcome the positioning of research at the heart of the Life Sciences Sector Plan, from the earliest stages of discovery science and beyond. We also welcome the focus on ensuring that the NHS embraces new discoveries and innovations – these will only have an impact if they get to patients quickly and effectively.  

    It’s reassuring to see a clear focus on implementation and accountability in the plan. This will help to ensure urgent action and real change. Medical research charities must be key delivery partners – they support R&D that focuses on patients, addresses areas of unmet need and accelerates impact.

    Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, says:    

    We are pleased to see the Life Sciences Sector Plan setting out an array of opportunities for action to accelerate the growth of the UK’s respiratory research and innovation sector.   

    There has been too little scientific progress for people living with lung conditions – the third biggest killer in the UK. This plan for investment, with its focus on innovation and access to health data for research, could help drive desperately needed improvements to the diagnosis and treatment of lung disease, which affects 1 in 5 people in the UK.  

    With effective implementation, this plan could lead to research investment that will save lives and significantly reduce the number of preventable A&E visits due to asthma attacks and COPD exacerbations. Furthermore, it has scope to increase the growth of the life sciences sector and will benefit the UK economy by cutting days lost to sickness.

    Louis Taylor CBE, CEO of the British Business Bank, said:  

    In the UK, we are very good at starting high-potential companies and creating breakthrough innovation, but what’s often lacking is the capital to scale these startups. The British Business Bank has been at the heart of growing the UK innovation economy for the last ten years. Today, the Bank is the largest investor in UK venture and venture growth capital funds and the most active late-stage investor in life sciences and deeptech. We welcome today’s Life Sciences Sector Plan and will continue to support the growth of this critical sector.

    Mike Fairbourn, Vice President & General Manager, UK & Ireland for Becton Dickinson said: 

    Becton Dickinson welcomes the UK government’s publication of the Life Sciences Sector Plan. The plan’s focus on accelerating regulatory approvals, streamlining procurement pathways and investing in innovative manufacturing underscores the crucial role of medical technology in driving better health outcomes and economic growth. We strongly support these commitments and stand ready to work hand-in-hand with government, the NHS and regulators to deliver on these ambitions. Together, we can unlock the full potential of the UK’s medical technology industry to bolster the UK life sciences sector and the wider economy, and to benefit patients across the country.

    Dr Daniel Mahony, Chair of the UK BioIndustry Association said:  

    Making the UK an outstanding place in which to start, grow, scale and invest in life science companies is key to driving UK economic growth.  The life science sector plan is right to focus on getting substantially more public and private investment in early-stage companies, improved access to data, trials and skills to help companies grow, and more streamlined regulation and market access pathways to get innovative medicines to NHS patients. We particularly welcome the focus on unlocking pension funds to increase investment in scaling life science companies. In this parliament, the UK has the opportunity to create a truly-world leading life sciences ecosystem that works for start-ups, scale-ups and established global companies alike.

    Dr Kevin Lee, CEO of Bicycle Therapeutics said:  

    Bicycle Therapeutics welcomes the government’s vision to make the UK a Life Sciences superpower as part of its bold and ambitious Industrial Strategy. We support the strategy’s aspiration to accelerate the growth of UK companies by encouraging investment in the sector, simplifying the regulatory environment, and leveraging the UK’s unique healthcare ecosystem to innovate in clinical trial design. At Bicycle, we view this plan as an opportunity to support the advancement of our work to unlock the potential of our Nobel prize-winning science and create new medicines for a wide variety of diseases, starting with cancer. We are excited by the prospect of working in an ever more innovative and productive sector that will see British scientific breakthroughs transform the lives of patients across the globe.

    Professor Sir Rory Collins, Principal Investigator and Chief Executive of UK Biobank, said: 

    The Life Sciences Sector Plan shows how, with long-term thinking, the UK can build on its many world-leading institutions and facilities to deliver a world-class base for science. UK Biobank is living proof of the value of long-term thinking and the impact it can have on life sciences, with projects like our recent decade-long work scanning 100,000 volunteers that is transforming health research and helping the NHS. 

    The UK government continually supports UK Biobank as shown by its £20 million investment for our project to measure proteins in the blood of our half a million volunteers. This investment is helping generate the world’s most comprehensive health data and, by making it so accessible, we’re effectively able to crowdsource the minds of the planet’s greatest experts. That accessibility is why philanthropists and industry from around the world keep amplifying the government’s investment, leading to more data that drives even more research.

    Professor Ugur Sahin, Managing Director, CEO and Co-Founder of BioNTech said:  

    We believe that innovative treatments reach patients faster when sectors collaborate towards a common goal. The renewed Life Sciences Plan reflects this spirit and has the potential to transform medicine through real progress in cancer care and beyond – both in the UK and globally.

    Helen Dent, CEO of British In Vitro Diagnostic Association (BIVDA) said: 

    This plan reflects the government’s understanding of the challenges facing the life sciences industry and their commitment to driving investment, growth, and innovation across the sector. 

    Pledges which reduce the cost and streamline the adoption of diagnostics, MedTech and genomics are hugely welcome, as are measures to introduce low-friction procurement and contracting mechanisms. 

    Ultimately, success will depend upon continued collaboration between government, industry, and the healthcare system to ensure its ambition is matched by delivery. BIVDA looks forward to supporting this process and bolstering the UK’s position as a world-leader in life sciences.

    Hyoungki Kim, CEO and Vice Chairman of Celltrion, said: 

    As a South-Korea based company with a global outlook, we are committed to adapting to the long-term dynamics of the markets we serve. The UK is a key supply destination for us, and we remain committed to supporting the NHS through the increased availability of biosimilar medicines in the coming years. The UK is an important supply destination for us, and we are planning substantial investments to expand our biosimilar medicine supply in the coming years. We therefore welcome the recognition in the life sciences plan that biosimilars are a critical means of delivering value to the NHS and, importantly, expanding patient access. This acknowledgement reinforces our confidence in prioritising the UK as a central focus of our global efforts.

    Massimiliano Collela, Chief Executive Officer of CMR Surgical, said: 

    We are grateful to the government for their support of leading UK Tech and Life Sciences scale-ups like CMR Surgical through the government’s Industrial Strategy, the 10 Year Health Plan and the Life Sciences Sector Plan.  With the government’s support, the UK innovation sector continues to flourish.

    Lars Petersen, President & Chief Executive Officer of FUJIFILM Biotechnologies, said: 

    FUJIFILM Biotechnologies warmly welcomes the UK government doubling down on its commitment to life sciences with this timely and ambitious new Sector Plan. 

    The UK has long been a global powerhouse in life sciences R&D – but what truly excites me about this plan is its potential to supercharge the life sciences ecosystem. By combining world-class discovery, cutting-edge development, and advanced manufacturing under one cohesive vision, the UK is positioning itself to not just lead in innovation but ensure the entire life sciences value chain flourishes. 

    I’m especially pleased to see the critical role of innovative medicines manufacturers, like FUJIFILM Biotechnologies, recognised as essential to the UK’s future growth. This isn’t just about planning; it’s a clear roadmap to unlocking our potential to fuel economic growth, spark groundbreaking innovation, and improve patient outcomes across the board. 

    The government’s pledge of £520 million in grants to expand the UK’s medicines manufacturing sector can also be a game-changer. Remaining globally competitive requires action, and this is exactly the kind of commitment needed to kickstart a new era for the UK’s life sciences. Combined with ongoing private-sector investment and the support of an empowered Life Sciences Sector Council, we’re looking at the foundation of a win-win scenario for government, business, patients, and innovators alike. 

    As one of the UK’s largest investors in innovative medicines manufacturing, FUJIFILM Biotechnologies stands ready to seize this opportunity. We look forward to helping turn this vision into a reality and build a stronger, more sustainable future for life sciences in the UK.

    Richard Stubbs, Chair of the Health Innovation Network said:  

    The UK is now in a race to the top to become a global powerhouse for the life sciences sector. To achieve this, we will need to go further to find, test and implement health innovations at pace and at scale. It is right that place-based innovation capacity and capabilities have been identified in the Life Science Sector Plan as a key enabler for the sector. 

    The Health Innovation Network is proud of the impact that we deliver with our partners in the NHS, academia and industry – from SMEs to multinationals – to improve patient outcomes, release capacity in the NHS to cut waiting lists and to drive economic growth, all priorities that are rightly recognised in this plan. The contribution the life sciences sector has to improve the health and wealth of the country is more evident now than ever. Through working locally with our vibrant life science sector, our health innovators, and our NHS staff we will deliver real change on the ground that has a national impact, and that supports the bold ambitions set out in the Life Sciences Sector Plan.

    Yamin Mohammed Khan, CEO of hVIVO said: 

    We were pleased to establish a working partnership with the Office for Life Sciences in support of their sector plan. The UK has a remarkable and longstanding legacy in life sciences, something which we at hVIVO are proud to be a part of as the world leading provider of human challenge trials. The UK has a proven track record of innovation that continues to thrive. As a global pillar in health research and life sciences, the UK plays a vital role in shaping the future of healthcare and scientific advancement. We’re excited to see how this 10-year plan unfolds, helping the UK maintain its global reputation and further strengthen its leadership in the life sciences sector.

    Mark Robinson, Vice President and General Manager, UK and Ireland, and North Europe at Illumina, said: 

    Illumina strongly supports the UK government’s ambition, outlined in the Life Sciences Sector Plan, for genomics to contribute to half of all healthcare interventions by 2035. The plan’s focus on integrated health data, streamlined clinical trials, and expanded genomic infrastructure aligns with Illumina’s mission to unlock the power of the genome to improve human health for all. Illumina’s longstanding partnerships in the UK have played a key role in advancing our understanding of the genome, and we look forward to continuing these collaborations to support the UK’s leadership in global genomic research and innovation.

    Dr Stella Peace, Interim Executive Chair of Innovate UK said: 

    The Life Science Sector Plan positions innovation as a critical engine with the potential to power breakthroughs, drive economic growth and transform lives. The plan sets out how we will unlock the full potential of UK life sciences by backing the businesses, researchers and technologies shaping the future of healthcare and delivering real societal impact.  Innovate UK look forward to being part of bringing this plan to life.

    David Marante, Vice President UK and Ireland at Intuitive, said: 

    We know how important equity of access to innovation is to improve patient care in the NHS.  For the last 2 decades we’ve worked together with NHS Trusts in England to implement da Vinci robotic-assisted surgery programmes, harnessing our innovations to help enhance patient and care team experience, and reduce waiting lists through increased productivity to ultimately improve patient outcomes. 

    With health innovation as a key pillar of the government’s vision for the UK’s Life Sciences sector, we’re excited to continue supporting NHS care teams to improve equity of access to minimally invasive care with da Vinci RAS, enabling patients to get back to what matters most.

    Mark Samuels, Chief Executive of Medicines UK, said:   

    Generics and biosimilars account for 4 in every 5 NHS prescriptions, making them a cornerstone of patient care and an essential part of the UK’s life sciences ecosystem. We welcome this plan’s recognition of their vital role.   

    The off-patent sector operates in a highly competitive global environment. To maintain supply and attract sustained investment, the UK must offer a policy and operating landscape that is both supportive and internationally attractive.   

    We are encouraged by the strategy’s ambition and clarity – particularly its objective to make the UK a world leader in the adoption of off-patent medicines, with a strong emphasis on biosimilars.

    A thriving off-patent sector delivers access and value for the NHS and forms the foundation for future pharmaceutical innovation and investment. We look forward to working with Government to deliver on this important agenda.

    Lawrence Tallon, Chief Executive of the Medicines and Healthcare products Regulatory Agency, said:  

    I welcome the publication of the Life Sciences Sector Plan and fully support its ambition to make the UK a global leader in life sciences and a country where innovation delivers for everyone. 

    It’s great to see the MHRA is recognised as a pivotal partner in delivering the plan’s vision – by supporting innovation, protecting public health, and making the UK a global destination for innovators to research, develop and launch cutting-edge medical products. 

    Working with our partners across the sector, we will continue to enable safe and effective innovation that benefits patients, the public, and the economy.

    Kit Erlebach, Chairperson of the UK’s Medicines Manufacturing Industry Partnership (MMIP) and Senior Director, Engineering at FUJIFILM Biotechnologies UK said: 

    The UK government’s new Life Sciences Sector Plan signals a clear and ambitious commitment to the future of life sciences in the UK. This plan provides a unique opportunity to build upon our nation’s strengths in research, development, and manufacturing, creating a fully connected and world-leading life sciences ecosystem, with innovative large and small medicines producers. 

    By articulating a clear vision for medicines manufacturing alongside discovery and development, the UK is laying the foundation for a thriving sector that benefits patients, drives innovation, and delivers economic growth. The focus on medicines manufacturing as a key component of this strategy is vital, providing the necessary support to strengthen the UK’s position on the global stage. 

    The allocation of £520 million in grants for expanding medicines manufacturing capabilities demonstrates the government’s dedication to fostering a competitive and sustainable industry. Combined with continued private-sector investment and collaboration across the sector, this targeted support will create new opportunities for innovation, employment, and improved health outcomes. 

    The Medicines Manufacturing Industry Partnership (MMIP) is proud to have contributed to support the development of this Sector Plan. In a rapidly changing international context, today’s announcement is a key step on the journey to enhance the UK’s international competitiveness. We are committed to working with Government to drive implementation of this plan, and the other necessary steps set out in the MMIP’s 10-year vision to deliver on our shared ambition.

    Darius Hughes, UK General Manager for Moderna, said:   

    Moderna welcomes the UK government’s Life Sciences Sector Plan as a bold and timely commitment to strengthening the UK’s position as a global leader in healthcare innovation and adoption.   

    Through our strategic partnership, we’ve invested in UK-based mRNA R&D and manufacturing, because we believe in the UK’s ability to turn scientific excellence into real-world impact.   

    This Plan gets the fundamentals right — from smarter regulation to investing in talent and unlocking the potential of health data — and we look forward to continuing our work together to deliver meaningful outcomes for patients, the NHS, and the economy.

    Professor Patrick Chinnery, Executive Chair of the Medical Research Council, said: 

    The new Life Sciences Sector Plan sets out a bold vision to transform how one of the UK’s most dynamic and globally competitive sectors delivers for our economy and for people around the world. 

    The Medical Research Council is committed to playing a central role in realising this vision by accelerating the translation of curiosity-driven research into innovations that support disease prevention, earlier diagnosis and better treatments. 

    In partnership with researchers, charities and industry, we will help more people live healthier, more productive lives, and attract further investment to strengthen the UK’s life sciences sector.

    Matthew Taylor CBE, Chief Executive of the NHS Confederation, said: 

    Health leaders will welcome the publication of the life sciences sector plan which will play a crucial role in building an NHS that’s fit for the future. Having a thriving UK life sciences and innovation sector is key to ensuring patients get access to the treatments and innovations they need and at the best value to the health system.  

    For the government’s NHS reforms to succeed a successful life sciences programme is key, and the sector benefits from using the NHS as a testbed and delivery partner for new innovations. We look forward to working with the Office of Life Sciences, the Department of Health and Social Care and NHS England to ensure the views of health system leaders are reflected in the implementation of the plan so that it can deliver for both the health system and life sciences sector.

    Dr Sam Roberts, Chief Executive of the National Institute for Health and Care Excellence (NICE), said: 

    We warmly welcome the publication of the government’s Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.  

    This comprehensive plan establishes a clear vision for how NICE, the NHS, and industry can collaborate to truly transform people’s lives through better, more equitable access to innovation. At NICE, we are committed to playing our part in ensuring that the UK remains at the forefront of life sciences innovation while delivering a sustainable and effective health service for all.

    Ros Deegan, CEO of OMass Therapeutics, said:  

    The new Life Sciences Sector Plan outlines ambitions that fit the UK’s world-leading capabilities and should help small and medium sized Life Sciences businesses scale, grow and keep innovation within the UK. As a growing biotechnology company with products approaching the clinic, we are encouraged to see actions designed to cut clinical trial approval times and improve access to capital – 2 critical factors that will benefit the sector and the wider economy.

    Dr. Lucinda Crabtree, Chief Financial Officer of Oxford Biomedica, said: 

    The UK government’s Life Sciences Sector Plan sets out a clear commitment to making the UK a global hub for health innovation. At OXB, we have experienced first-hand how targeted government support — including funding from Innovate UK — can help unlock growth and build globally competitive capabilities. The plan’s focus on accelerating clinical trial processes, streamlining regulatory pathways, and investing in manufacturing, genomics, and health data infrastructure will support innovation and improve access to breakthrough treatments. These initiatives are vital to establishing the UK as a key market to scale life sciences businesses, attract investment and world-class talent, and drive long term economic growth.

    Gordon Sanghera CBE, CEO and Co-founder of Oxford Nanopore Technologies, said: 

    The UK’s ambition to further expand the integration of genomic and molecular data into health systems and the economy – at scale – is exactly the kind of bold infrastructure investment that can improve lives and drive economic growth. In that system, being able to move quickly from innovation to implementation is essential to translating UK science into global health and economic impact.

    Roland Sinker CBE, Chief Executive of Cambridge University Hospitals NHS Foundation Trust, said:  

    As I outlined in the Innovation Ecosystem Programme report, there is a significant opportunity to deliver meaningful benefits to the NHS and patients through innovations developed by UK life sciences companies. I fully support the Life Sciences Sector Plan and its clear commitments to advancing research, enabling UK life sciences to thrive, and accelerating health innovation. These actions are essential to ensuring that NHS staff and patients are among the first to benefit from the latest breakthroughs.

    Richard Saynor, CEO of Sandoz said:  

    We welcome the government’s commitment to becoming a world leader in the uptake of off-patent medicines. The target of £1 billion of savings from biosimilars is both realistic and achievable. Increasing their use will unlock greater worker productivity and increase the health of the UK population – a major contribution to the government’s growth imperative. As a committed partner to the NHS and government, Sandoz will dedicate resources and expertise to realise the goals for the off-patent sector within the Life Sciences Strategy.

    Neil Daly, CEO and Founder of Skin Analytics, said: 

    We welcome the clear action plan in the Life Sciences Sector Plan for streamlining and speeding up the adoption of proven healthcare technologies and feel the plan will make a meaningful difference to UK health innovators. In skin cancer, this means that the NHS can move much more swiftly to establish appropriately regulated autonomous AI triage as standard practice for all patients. This will find more cancers, free up clinician time and save taxpayers’ money.

    Dr Michael Spence, University College London President and Provost said: 

    Universities will be at the heart of making the UK the leading life sciences economy in Europe. With its backing for world-class research and clinical trials, the Life Sciences Sector Plan will help us achieve even more. 

    London is a global centre for innovation, with Euston already a leading area for life sciences where world-class universities, healthcare, and life science companies come together. With new investments in Oriel at St Pancras Way with Moorfields Eye Hospital, and a state-of-the art neuroscience facility at Grays Inn Road, UCL is at the heart of making the area a global leader. The new Life Science Hub at Euston station is a step towards realising the huge potential in this area and achieving the government’s ambitions 

    John-Arne Røttingen, CEO of Wellcome, said: 

    The ambition set out in the Life Sciences Sector Plan is hugely welcome. Life sciences are a historic strength of the UK, and this strategic vision is important to cement the country’s advantage in the future. The plan’s emphasis on the importance of early-stage research is particularly shrewd. Basic discovery science underpins later health breakthroughs and clinical trials, making it the essential bedrock for a thriving research economy.  

    The focus on speeding up trials and on data infrastructure for research will not only lead to real impact for patients but also strengthen the UK’s attractiveness to innovative researchers and businesses.  

    If the level of ambition in the plan is matched by meaningful action and investment, the UK will be well on its way to securing its place as a global life sciences leader.

    Notes to editors

    The full collection of Industrial Strategy sector plans can be found here.

    DSIT media enquiries

    Email press@dsit.gov.uk

    Monday to Friday, 8:30am to 6pm 020 7215 3000

    Updates to this page

    Published 16 July 2025

    MIL OSI United Kingdom –

  • MIL-OSI Asia-Pac: LCQ 15: Formulating a comprehensive population policy

    Source: Hong Kong Government special administrative region

    Following is a question by the Hon Nixie Lam and a written reply by the Secretary for Home and Youth Affairs, Miss Alice Mak, in the Legislative Council today (July 16):
     
    Question:

    According to data from the Census and Statistics Department, Hong Kong’s total fertility rate in 2024 was only 0.841, far below the 2.1 level required for population replacement. Furthermore, a survey by a youth service organisation indicated that only 36 per cent of young people in Hong Kong who had responded in the survey expressed a preference for marriage or childbearing. Another survey showed that just around 23.27 per cent of respondents aged between 19 and 29 expressed a desire to have children, ranking among the lowest levels globally. There are views that the Government should adopt measures to enhance marriage and fertility rates among young people and develop a comprehensive population policy to avoid population ageing and workforce shrinkage. In this connection, will the Government inform this Council:
     
    (1) whether it will commence a systematic survey and study on the marriage and fertility situation of young people in Hong Kong, so as to deeply analyse the core factors influencing their decisions regarding marriage and childbearing, particularly through assessment in areas such as financial burdens, housing difficulties and job stability, with a view to gaining a more precise understanding of their concerns and expectations; if so, of the direction and timetable of the survey and study; if not, the reasons for that;
     
    (2) as there are views pointing out that young people’s lack of knowledge and confidence in future planning and gender relations indirectly undermine their willingness to marry and have children, whether the Government will consider, through cross-departmental collaboration, integrating existing fertility support measures for young people (e.g. child-rearing subsidies, priority quotas for public housing allocation, and childcare services for working families) and consolidating such information within the Home and Youth Affairs Bureau’s “HKYouth+” mobile application, as well as adding a designated information corner to the application that covers topics such as reproductive health, sex education, and marriage and fertility support, with a view to strengthening support for young people in the aspects of affective education and reproductive health information; if so, of the timetable; if not, the reasons for that; and
     
    (3) as there are views pointing out that although the Government has established the Human Resources Planning Commission to follow up on population policy, Hong Kong’s current population policy still lacks comprehensiveness, whether the Government will review the Commission’s work or establish a task force coordinated by an official at the level of Secretary of Department to institutionally integrate cross-departmental resources, with a view to formulating more comprehensive population policy objectives for Hong Kong to address the long-term challenges of population development?
     
    Reply:
     
    President,
     
    In consultation with the Chief Secretary for Administration’s Office, the Deputy Chief Secretary for Administration’s Office, the Labour and Welfare Bureau (LWB), the Housing Bureau (HB), the Financial Services and the Treasury Bureau (FSTB) and the Health Bureau (HHB), the consolidated reply to the questions raised by the Hon Nixie Lam is as follows:
     
    (1) & (2) The Census and Statistics Department (C&SD) has been regularly collating data related to marriage and fertility trends across different age groups. The C&SD also publishes feature articles from time to time, giving a brief account of the marriage and fertility trends in Hong Kong and analysing the factors underlying such trends.
     
    Hong Kong and many countries or places worldwide are facing a decline in fertility rate. In the face of this challenge, the Government must formulate measures to raise fertility rate. As such, the Chief Executive (CE) announced in his 2023 Policy Address a host of measures to promote fertility and create a conducive environment for childbearing through a “combination punches” approach. These measures include providing Newborn Baby Bonus, giving families with newborns priority on flat selection and allocation, enhancing child care support and increasing tax concessions. Office/ bureaux implementing the measures include the Deputy Chief Secretary for Administration’s Office, the HB, the LWB, the HHB, the Home and Youth Affairs Bureau (HYAB) and the FSTB.
     
    The Hong Kong Housing Authority (HA) has implemented the Families with Newborns Allocation Priority Scheme and the Families with Newborns Flat Selection Priority Scheme to encourage childbearing by giving incentives to family applicants of public rental housing (PRH) and subsidised sale flats (SSF) sale exercises.  
     
    Regarding the allocation of PRH, the HA has implemented the Families with Newborns Allocation Priority Scheme since April 1, 2024. PRH family applications with babies born on or after October 25, 2023 and aged one or below are credited one year of waiting time. As at end-June 2025, about 5 000 PRH applications have been credited one year of waiting time under the scheme, of which about 420 families have already been successfully housed to PRH.
     
    As for SSF, starting from the Sale of Home Ownership Scheme (HOS) Flats 2024 (HOS 2024), the HA has implemented the Families with Newborns Flat Selection Priority Scheme which was announced in the 2023 Policy Address. A quota of about 40 per cent of the new flats for sale (i.e. 2 900 flats) under HOS 2024 were set aside for eligible applicants under the Families with Newborns Flat Selection Priority Scheme and the Priority Scheme for Families with Elderly Members for balloting and priority flat selection. Family applicants of HOS with babies born on or after October 25, 2023 are eligible if their children are aged three or below on the closing day of the application.
     
    During the application period of HOS 2024, the HA received a total of around 106 000 applications. Among them, around 50 000 were family applicants, of which around 19 000 (i.e. about 40 per cent) applied under the Priority Scheme for Families with Elderly Members and Families with Newborns Flat Selection Priority Scheme. Among these 19 000 applicants, 800 applicants have successfully purchased flats through the Families with Newborns Flat Selection Priority Scheme. If eligible families applying under the Families with Newborns Flat Selection Priority Scheme fail to purchase a flat under HOS 2024, they may still apply under the Scheme for priority flat selection as long as their children are aged three or below on the closing day of the application in subsequent SSF sale exercises.
     
    The Government announced in the 2023 Policy Address that a cash reward of $20,000 will be provided to eligible parents for each baby born from October 25, 2023, for a period of three years. Starting from October 25, 2023, parents can submit an application for the bonus at the same time when registering the birth of their baby and applying for a birth certificate. As of end-June 2025, a total of 49 567 qualified applications have been received, and the bonus has been distributed to 48 984 applicants, at a total amount of approximately $979 million. The Deputy Chief Secretary for Administration’s Office is carrying out a review of the Newborn Baby Bonus Scheme.
     
    The Government has been supporting parents who cannot take care of their children temporarily through subsidising non-governmental organisations (NGOs) to provide a variety of day child care services, including Child Care Centres (CCCs), the After School Care Programme and the Neighbourhood Support Child Care Project (NSCCP). To strengthen support for working families in childbearing, the Government has announced the setting up of additional 11 aided standalone CCCs in phases, doubling the total number of service places to reach around 2 000. The Government is extending the After School Care Programme for pre-primary children to cover all districts in phases, and increasing the number of service places under the NSCCP to 2 500 with the estimated number of beneficiaries increasing to 25 000. The Social Welfare Department will also provide information and assistance to private organisations applying for registration to operate CCCs, and encourage private organisations to provide child care support for their employees. Meanwhile, the Government reviews the Working Family Allowance (WFA) Scheme from time to time. The rates of the household and child allowances under the WFA Scheme have been increased by 15 per cent across the board with effect from April 2024, benefiting all households receiving the WFA. The WFA Scheme provides additional allowances for relevant childbearing families, and increasing the rates of the WFA helps further alleviate the burden of grassroots working families. Taking a four-person household with two eligible children as an example, the maximum monthly WFA they may receive have increased from the original amount of $4,200 to $4,830 at present.
     
    As regards tax concessions, starting from the year of assessment (YA) 2023/24, the basic child allowance and the additional child allowance for each child born during the YA have been raised from $120,000 to $130,000. In addition, starting from YA 2024/25, for taxpayers who live with their children born on or after October 25, 2023 and meet the prescribed conditions, the deduction ceiling for home loan interest or domestic rents will be raised from $100,000 to $120,000 for a maximum of 19 YAs. These measures can encourage childbearing by helping taxpayers to alleviate their financial burden from raising children.
     
    As regards antenatal services, currently the Obstetrics and Gynaecology Departments of the Hospital Authority and the Maternal and Child Health Centres (MCHCs) of the Department of Health (DH) provide free antenatal services for all local pregnant women who are eligible persons (who generally refer to holders of Hong Kong Identity Cards or such other persons as may be approved by the Chief Executive of the Hospital Authority/ Director of Health) to ensure the health of the pregnant women and their foetuses. The scope of services includes the first antenatal check-up, personal and family medical history, as well as various investigations and vaccinations conducted by doctors according to the clinical needs of individual pregnant women.
     
    Besides, as announced in the 2024 Policy Address, the DH will revamp maternal and child health and family planning services to strengthen pre-pregnancy counselling and parental education and promote healthy fertility. The DH will provide the new pre-pregnancy health services to reproductive age group women at the MCHCs in phases, support women in preparing for pregnancy through health consultation and counselling, health assessments, arrangement of blood tests and other investigations, and provide nutritional dietary and lifestyle advice, to align with the Government’s policy of encouraging and promoting healthy fertility, as well as protecting and advancing maternal and child health. Details on the above initiatives will be announced at an appropriate juncture. In addition, the DH will review and adjust the scope of the subsidised family planning service currently provided by NGOs, so as to dovetail with the Government’s policy of encouraging and promoting healthy fertility.
     
    The HYAB has been supporting the work of the Family Council (the Council) in promoting a culture of loving families to the general public through organising different publicity programmes and activities. In October 2024, the HYAB and the Council launched the five-year Funding Scheme on the Promotion of Family Education (the Scheme). With an annual funding of $8 million, the Scheme subsidises non-profit-making community projects in promoting family education. NGOs may, based on societal needs, apply to the Scheme for funding to implement projects related to topics such as family building, new parents, and marriage-related. On the other hand, the Council has been encouraging the wider adoption of more diversified and flexible family-friendly employment practices (FFEPs) in the community. Measures include launching promotional videos entitled “Family-friendly Workplace”, which feature various FFEPs adopted by local companies, and collaborating with the Radio Television Hong Kong to produce radio programmes to promulgate different types of FFEPs. These measures will also help foster a pro-family environment.
     
    The HYAB launched the first release of the “HKYouth+” youth mobile application in March 2024, and has been continuously updating it to cater to the needs of young people. Its content cover various areas, including personal development opportunities, local hot topics, national development, world news, arts and leisure, innovation and technology, physical and mental wellness. It aims to help young people expand their knowledge, explore interests and enrich themselves in different aspects. The HYAB will work with relevant bureaux and departments to encourage them to make use of “HKYouth+” for strengthening promotion of various support measures to the youth community.
     
    (3) The population policy straddles a wide range of policy areas, involving various bureaux. For the current term of the HKSAR Government, in addition to the standing committees, the CE and Secretaries and Deputy Secretaries of Departments are now providing high-level steer as necessary through various channels, such as working groups and inter-departmental meetings, to coordinate relevant inter-departmental work.
     
    Chaired by the Chief Secretary for Administration, the Human Resources Planning Commission (HRPC) consolidates resources and efforts of the Government and various sectors to examine, review and holistically co-ordinate policies and measures on human resources, including issues pertaining to the population policy. The HRPC is a high-level policy platform, with eight policy secretaries, including Secretary for Commerce and Economic Development, Secretary for Constitutional and Mainland Affairs, Secretary for Education, Secretary for Financial Services and the Treasury, Secretary for Health, Secretary for Innovation, Technology and Industry, Secretary for Labour and Welfare and Secretary for Security; the Government Economist; the Commissioner for Census and Statistics and the Chairmen of the Employees Retraining Board, the Hong Kong Council for Accreditation of Academic and Vocational Qualifications and the Vocational Training Council as ex-officio members; and non-official members drawn from a diverse mix of experts and stakeholders from different fields and sectors. Since its establishment in 2018, the HRPC has looked into a number of issues to tackle the demographic challenges, facilitating the Government to formulate and refine the relevant policies and measures.
     
    Currently, population policy measures have been subsumed under the portfolios of various bureaux as part of the ongoing efforts. As the Government’s existing steering and inter-departmental co-ordination mechanism are flexible and effective, the Government does not consider it necessary to set up a separate structure for the work on the population policy.

    MIL OSI Asia Pacific News –

  • MIL-OSI United Kingdom: Mayor of London warns UK must not ‘pull up the drawbridge to international students’ in landmark speech

    Source: Mayor of London

    • Mayor shares new analysis of major economic benefits from international students in speech hosted by Imperial College London’s new Ghana hub
    • City Hall projections put annual economic benefit of overseas students at UK universities around £55bn, with £12.5bn from those based in London
    • Sadiq will warn that ministers who want to “pull up the drawbridge to international students” would “slow down growth and leave working people in Britain worse off” as he stresses economic benefits of attracting the best global talent to study, work and live here

    Mayor of London, Sadiq Khan, is urging the government not to make it harder for international students to study in the UK as he reveals new analysis showing they contribute £12.5bn to the capital and £55bn to the national economy every year.

    The Mayor is in Ghana today (Wednesday 16 July) as part of his historic five-day trade mission to Africa, banging the drum for the capital as a place to invest and strengthening ties with countries across the continent. A major speech in Accra will see Sadiq make the case for welcoming students from around the world, and warn that proposals for a new levy on their university fees would be damaging to London and the UK’s economy.

    The UK Government is currently considering a new levy on income that English universities generate from international students as part of its immigration whitepaper, which could not only put students off coming here from overseas but also create a substantial extra financial burden for already stretched universities. The Mayor’s speech today will warn that this levy would be “an act of immense economic self-harm”.

    Today the Mayor will deliver a keynote speech on the power of education, innovation and entrepreneurship to Ghanaian students hosted at Imperial College London’s Accra hub. With five per cent of London’s higher education population coming from Africa [1], he will stress that London is open to global talent and make the positive case for international study.

    Latest analysis by London Economics revealed a more than £10 billion rise in the economic contribution of international higher education students to the UK economy, from £31.3bn in 2018/19 to £41.9bn in 2021/22 – leading City Hall economists to project it could hit £55bn in the current academic year on the basis of historical trends [2].

    London accounts for almost a quarter of this national impact, representing around £10bn in the latest data and projected to reach £12.5bn this year [3]. International students in the capital created an average net benefit of £1,040 per Londoner over the course of their studies, as beyond their university fees they contribute by spending in all sectors of the economy and bringing family or friends to visit [4].

    This positive economic impact spreads across the UK, with international students making a £58m net contribution to the national economy per parliamentary constituency during their studies – providing an equivalent £560 benefit for each local resident [5]. They also bring a longer-term labour market value, as many stay here after their studies to work in key economic sectors from tech and AI to finance and creative industries.

    Imperial is the first UK university with a permanent base solely focused on science, technology and innovation in Africa – building on the rapidly rising number of advancements and breakthroughs Imperial has made working with researchers in Ghana over recent years. Imperial Global Ghana serves as an academic hub to support high-impact collaboration in cutting-edge fields from medical diagnostics to urban health and AI to climate science.

    As well as current students, the Mayor will meet recent graduates including Shirgade Laryea, a Ghanaian alumna of Imperial College London’s Business School who is now a rising star in the UK-Ghana Chamber of Commerce. Other alumni success stories include Affinity bank founder Tarek Mouganie, Liquify fintech platform COO Alberta Asafa-Asomoah and former Anglo Gold Ashanti CEO Sir Sam Jonah.

    The Mayor is expected to say in his speech: “There are people at home who believe we should pull up the drawbridge to international students, or punish universities that choose to welcome people from around the world.

    “Our new analysis shows international students bring in tens of billions for our economy each year over the course of their studies, including £12.5 billion in London alone. And when they graduate, they go on to make our city – and our country – a better place to be.”

    The Mayor will add: “Closing our country to global talent would be an act of immense economic self-harm – one that would slow down growth and leave working people in Britain worse off than before. That’s why I’m calling on our Government not to make it harder for international students to study in the UK.

    “On my watch, London will be as open as ever… but I think we must do more. We cannot simply wait for the world to come to London; we must bring London to the world.”

    Imperial College London President, Professor Hugh Brady, said: “Imperial Global Ghana creates a bridge between London and Accra so you get a flow of ideas, talent and capital. The hub supports hundreds of entrepreneurs and scientists in West Africa, and enables talented students to further their studies in London.

    “International students are an essential part of Imperial’s global community. They bring diverse perspectives, new ideas, and fresh approaches to tackling today’s most complex challenges. We are pleased that London and the UK remains a top destination and welcoming environment for international students.”

    Imperial Global Ghana Associate Director, Clare Turner, said: “A truly global city – and its universities – thrive when people with different cultural, social and intellectual perspectives come together. At Imperial Global Ghana, our focus is on building long-term equitable research and education partnerships that both inspire the next generation of leaders and innovators, and work towards a greater understanding of complex global challenges – such as climate change, the energy transition, and access to quality healthcare.”

    University of Ghana Vice Chancellor, Professor Nana Aba Appiah Amfo, said: “It is a great honour to welcome the Mayor of London, Sir Sadiq Khan, to Ghana and to the University of Ghana. His presence underscores the growing importance of global partnerships in shaping the future of education and innovation; we look forward to deepening these ties as we empower the next generation of changemakers on the continent and beyond.

    “We are especially proud of our collaboration with Imperial College London – one that continues to thrive through initiatives such as the Impact Hub and other areas such as digital diagnostics, innovation and entrepreneurship, public health, environmental sustainability, and vaccine manufacturing clearly stipulated in a five-year Memorandum of Understanding signed in 2024. This innovative cooperation is hinged on our five strategic priorities: transformative student experience, impactful research, commitment to our faculty and staff, engagement and partnerships, as well as sustainable resource mobilisation and stewardship.”

    London Higher CEO, Liz Hutchinson, said: “London’s universities are world-leading because they are international, with overseas students enriching not just the economy but also the learning experience and the vibrant, creative communities that the capital is famous for. International graduates are crucial to London’s talent pipeline, joining the many businesses based here or as entrepreneurs.

    “This is a time when we should be strengthening our position as a hub for talented individuals from across the world. The government’s proposed levy on international students does the opposite. With our partners in the sector, in industry and in London, we stand ready to collaborate with Government and sector colleagues to find alternative solutions that enhance rather than damage London’s international competitiveness.”

    Universities UK Chief Executive, Vivienne Stern, said: “The Mayor of London will see first-hand the global reach of UK universities and their contribution to the cutting-edge research tackling shared challenges. He is right to champion the power of education, and this new analysis once again highlights the economic value of international students to the UK.

    “We are fortunate to be a destination of choice for students from all over the world; they contribute to our research landscape and our communities, as well as enabling UK students to benefit from diverse perspectives. We should be proud of this and work hard to make sure that international students feel welcome.”

    Business LDN Chief Executive, John Dickie, said: “At a time when some of our rivals are closing their doors to international students, the UK should do all it can to reinforce its attractiveness to talented people from across the globe.

    “London is the world’s best city to study, but the Government’s plans to introduce a new levy on the income generated by overseas students risks damaging our competitiveness. Ministers should scrap these plans to avoid damaging growth, exacerbating the higher education sector’s financial challenges and undermining our soft power.”

    Over the course of five days Sadiq will visit four cities – Lagos, Accra, Johannesburg and Cape Town – to boost trade links with London and build on extensive connections with the capital’s growing African diaspora. The Mayor’s growth agency London & Partners will also host a trade delegation of 27 London-based companies that are looking to grow their businesses and access opportunities in this dynamic and important region of the world.

    MIL OSI United Kingdom –

  • MIL-Evening Report: How a drone delivering medicine might just save your life

    Source: The Conversation (Au and NZ) – By Centaine Snoswell, Senior Research Fellow, Centre for Health Services Research, The University of Queensland

    Flystock/Shutterstock

    Drones can deliver pizza, and maybe one day your online shopping. So why not use them to deliver urgent medicines or other emergency health-care supplies?

    Trials in Australia and internationally have shown the enormous potential for drones to work with existing health services to deliver medicine, medical equipment, pathology samples, or provide surveillance in medical emergencies.

    Some emergency services are already using drones to deliver health care. Earlier this year, NSW Fire and Rescue used a drone to deliver essential medicine to someone stranded by floodwater while they were supported by phone. Follow the journey from launch to pick-up in the video below.

    Drones have enormous potential

    Drones are appealing because they can rapidly transport medical supplies, especially without traffic delays. They can quickly access places other forms of transport cannot, including remote or difficult-to-reach areas, such as cliffs. And when drones cannot land, they can use a parachute to safely drop their delivery. This means drones can deliver essential items, such as antivenom or defibrillators, before first responders reach the scene.

    Drones can also support medical efforts by providing birds-eye-view images and scans of sites before humans are sent in. This means it’s safer for first responders, such as ambulance crew, as they have a better idea of what to expect when they arrive in-person.

    Drones help find missing persons

    An Australian trial this year involved NSW Ambulance using drones for search and rescue in remote and hard-to-reach locations.

    Specially trained paramedics piloted the drones during the two-month trial. Drones had high-intensity search lights and used thermal imaging to help find missing persons. Video and audio capabilities allowed paramedics to communicate with the person once they were found, and to monitor them and the situation.

    This trial is a great example of how drones can be used to extend the capacity of first responders.

    Trials like this can also collect data about how well the drones work for different teams and circumstances. The more data we have about how drones can support first responders and medical staff, the better we can design services that include them.

    Drones send samples to the lab

    Darling Downs Health in Queensland has also been trialling drones. These transport pathology samples and pharmaceuticals between small rural hospitals in Nanango or Wondai, and the larger regional hospital in Kingaroy.

    This means pathology samples can be flown to the laboratory as soon as they are collected, instead of waiting for a courier. Patients can therefore be diagnosed and begin treatment earlier.

    The Mater Hospital in Brisbane is setting up a similar service to provide pathology services to the Moreton Bay islands. This service aims to avoid transporting pathology samples by ferry.

    Drones for beaches, hearts, or up mountains

    Surf Life Saving Queensland is running a regular drone patrol. Drones monitor shark activity and help co-ordinate responses, such as beach closures.

    Drones have been used in New South Wales to drop flotation devices to swimmers in danger.

    Swedish researchers have trialled using drones to deliver defibrillators to people who have called an ambulance and are suspected of being in cardiac arrest. A drone could deliver a defibrillator in 92% of suspected cardiac arrests. The delivery time was quicker than an ambulance 64% of the time.

    In mountainous regions of India, drones are used to deliver medications to remote health services as part of the Medicine from the Sky program.

    But there are limitations

    Despite drones’ potential to supplement existing health and emergency services, there are limitations.

    Their battery life and weight affects flight time. For instance, the NSW Ambulance trial reported the range of drones is 7 kilometres from base. So, it may be necessary to transport the drone closer to the area of need before it’s launched. This may reduce drones’ usefulness for rural and remote areas. There are also weight limits to what they can carry.

    Some drones may be limited to flying during the day. They may not be able to fly in poor weather conditions, reducing their effectiveness during natural disasters. Temperature and humidity can spoil pathology samples and some medications, which restricts what drones can be used for.

    Existing legislation may also limit where drones can operate.

    Is this the future?

    Many promising trials show drones can effectively help support health and emergency services.

    However, many of these trials have yet to released their final evaluations. So we still need evidence of whether drones improve health outcomes and are cost-effective. This would be essential if we were to routinely use drones to support health care and emergency services beyond these trials.

    The health-care sector would also benefit by learning from companies in other sectors that use drones. This would give the health sector insights into how and when to use drones safely, and how to scale up operations cost-effectively.

    The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

    – ref. How a drone delivering medicine might just save your life – https://theconversation.com/how-a-drone-delivering-medicine-might-just-save-your-life-259904

    MIL OSI Analysis – EveningReport.nz –

  • MIL-OSI United Kingdom: Plea from Manchester health chiefs: Let’s not go back for the future. Why we have to keep Victorian diseases in the past

    Source: City of Manchester

    Don’t let history repeat itself, says Manchester’s public health team, as they urge parents and carers to take action now to stop preventable Victorian diseases like Measles and typhoid return

    Their plea comes as schools prepare for summer and families are set to travel for their holidays – which also increases the possibility for picking up or spreading diseases in unvaccinated people.

    In particular, cases of measles are starting to increase across the country. There was no vaccination available during the Victorian era, which meant rapid spread of the disease and the mortality rate was high from associated complications like pneumonia.

    Without today’s knowledge and approach they were frequently limited to using soaps and oils. “We can’t go back to the past for the future,” says Dr Cordelle Ofori, Manchester’s Director of Public Health. “In Manchester we want everyone to have the chance to have as much protection as possible and take up our free vaccinations offer.

    “It’s totally understandable that parents or carers want as much detail as possible about the vaccinations, so please do ask any questions from your doctor or pharmacist, or health champions in your areas. NHS-trained health champions are local people, who live near you and are able to ask questions to medical teams on your behalf.”

    Cllr Thomas Robinson, Manchester City Council’s Executive Member for Healthy Manchester and Adult Social Care, continues: “It’s never too late to come forward for the MMR vaccination – and if you do not know if you or your family have had it, please ask your GP. Where there is no record of having had the vaccinations, it is better to have them to be on the safe side.”

    As part of a preventative stance, Manchester is writing to all parents or carers of school-age children to give them more details on vaccinations and other travel advice.

    They are also sending it with a link to a bespoke guide for Manchester on how the body can be affected by certain diseases when people are not vaccinated. The booklet can be downloaded here: https://www.manchesterlco.org/childhood-vaccinations/

    This is so that parents can act quickly now through free vaccinations with their GP and also so that they are ready for when schools return in September.  Key travel advice for parents or carers ahead of the holidays has a focus on Hepatitis A, Typhoid, Measles, Mumps and Rubella (MMR) – all of which were prevalent in Victorian times.

    Hepatitis A This affects your liver. You can catch it from dirty water or food, or from someone who has it. Your child might:

    • Feel very hot and tired
    • Feel sick
    • Have yellow eyes or skin
    • Have dark urine
    • Have a sore tummy

    For more detail: https://www.nhs.uk/conditions/hepatitis-a/

    Typhoid This affects your whole body and can be very dangerous. Your child might:

    • Feel very hot
    • Have a headache
    • Have sore muscles
    • Have loose stools or constipation

    For more detail: https://www.nhs.uk/conditions/typhoid-fever/

    Measles This spreads very easily from person to person. It can be very dangerous for young children and can even cause brain swelling. Your child might:

    • Have a runny nose
    • Sneeze and cough
    • Have red, sore eyes
    • Feel very hot
    • Have red-brown spots on their skin

    For more detail: https://www.nhs.uk/conditions/measles/  

    MIL OSI United Kingdom –

  • MIL-OSI Russia: Don’t miss your station: all escalators lead to Polytech

    Translation. Region: Russian Federal

    Source: Peter the Great St. Petersburg Polytechnic University –

    An important disclaimer is at the bottom of this article.

    The heat is on: real summer has arrived in St. Petersburg, and applicants have just over a week to apply for admission to a university. There are many opportunities, but it is difficult to make the right choice. Not all graduates leave school with a clear understanding of where exactly they will go to get higher education. Sometimes a strong emotion becomes a turning point for making a decision. For example, many students stay to study at the Polytechnic University under the impression of the beauty of its buildings and park. But first, they need to get there. Potential students will be helped by… superheroes of the Polytechnic Universe.

    Now you can see them on light boxes in the vestibules and on the escalators of eleven stations of the St. Petersburg metro, and they will definitely not let you go astray. If you get on the wrong line, change to the red one. If you hear in the train: “The next station is Politekhnicheskaya”, get off, this is where you need to go. Go up the escalator, the superheroes will wave their hand in greeting – and now you are outside, and you are greeted by the snow-white main building of the Polytechnic and a green park with a 46-meter old tower. You must admit, there is no better place for student life.

    “This year we have kept the slogan of the previous admissions campaign, “You are the main hero!” It has proven itself well,” said Dmitry Voronov, Head of the Department for Promotion of Educational Programs at SPbPU. “The corporate style with comic book characters was created by the Visual Communications Department of the Public Relations Office, and the advertising layouts were prepared by the Department for Promotion of Educational Programs.”

    Let us recall that in 2024, almost 145 thousand applications were submitted for budget places in the bachelor’s and specialist’s degree programs at the Polytechnic University – this is 70% more than in 2023. It is too early to sum up the results of the 2025 admissions campaign, but by July 15, 108,126 applications had already been submitted for all forms of study in the bachelor’s and specialist’s degree programs. The largest number – 26,000 applications – were received by the Institute of Computer Science and Cybersecurity, in second place (25,000) – the Institute of Industrial Management, Economics and Trade, in third (12,000) – the Institute of Mechanical Engineering, Materials and Transport.

    Among the areas of training, the most popular are “Software Engineering”, “Construction”, “Information Systems and Technologies”.

    The admissions committee notes the continued high demand of applicants for all areas of the IT sphere and the growing interest in such areas of training as: “Nuclear Power Engineering and Thermal Physics”, “Thermal Power Engineering and Thermal Engineering”, “Automation of Technological Processes and Production”, “Biotechnology”.

    The acceptance of documents continues. The rules of the admission campaign and its progress can be found aton our website.

    Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.

    .

    MIL OSI Russia News –

  • MIL-OSI Russia: Don’t miss your station: all escalators lead to Polytech

    Translation. Region: Russian Federal

    Source: Peter the Great St. Petersburg Polytechnic University –

    An important disclaimer is at the bottom of this article.

    The heat is on: real summer has arrived in St. Petersburg, and applicants have just over a week to apply for admission to a university. There are many opportunities, but it is difficult to make the right choice. Not all graduates leave school with a clear understanding of where exactly they will go to get higher education. Sometimes a strong emotion becomes a turning point for making a decision. For example, many students stay to study at the Polytechnic University under the impression of the beauty of its buildings and park. But first, they need to get there. Potential students will be helped by… superheroes of the Polytechnic Universe.

    Now you can see them on light boxes in the vestibules and on the escalators of eleven stations of the St. Petersburg metro, and they will definitely not let you go astray. If you get on the wrong line, change to the red one. If you hear in the train: “The next station is Politekhnicheskaya”, get off, this is where you need to go. Go up the escalator, the superheroes will wave their hand in greeting – and now you are outside, and you are greeted by the snow-white main building of the Polytechnic and a green park with a 46-meter old tower. You must admit, there is no better place for student life.

    “This year we have kept the slogan of the previous admissions campaign, “You are the main hero!” It has proven itself well,” said Dmitry Voronov, Head of the Department for Promotion of Educational Programs at SPbPU. “The corporate style with comic book characters was created by the Visual Communications Department of the Public Relations Office, and the advertising layouts were prepared by the Department for Promotion of Educational Programs.”

    Let us recall that in 2024, almost 145 thousand applications were submitted for budget places in the bachelor’s and specialist’s degree programs at the Polytechnic University – this is 70% more than in 2023. It is too early to sum up the results of the 2025 admissions campaign, but by July 15, 108,126 applications had already been submitted for all forms of study in the bachelor’s and specialist’s degree programs. The largest number – 26,000 applications – were received by the Institute of Computer Science and Cybersecurity, in second place (25,000) – the Institute of Industrial Management, Economics and Trade, in third (12,000) – the Institute of Mechanical Engineering, Materials and Transport.

    Among the areas of training, the most popular are “Software Engineering”, “Construction”, “Information Systems and Technologies”.

    The admissions committee notes the continued high demand of applicants for all areas of the IT sphere and the growing interest in such areas of training as: “Nuclear Power Engineering and Thermal Physics”, “Thermal Power Engineering and Thermal Engineering”, “Automation of Technological Processes and Production”, “Biotechnology”.

    The acceptance of documents continues. The rules of the admission campaign and its progress can be found aton our website.

    Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.

    .

    MIL OSI Russia News –

  • MIL-OSI United Nations: Yemen: Security Council extends UN mission in crucial port city amid escalating Red Sea strife

    Source: United Nations 4

    Adopted unanimously, the resolution extending the UN Mission to support the Hudaydah Agreement (UNMHA) until 28 January 2026, underscores the Mission’s critical role in maintaining fragile stability amid signs of renewed military escalation and deepening humanitarian need.

    The resolution – 2786 (2025) – reaffirms the Council’s support for the 2018 Stockholm Agreement, including the ceasefire in the Houthi-controlled port city – and demilitarisation of its docks, where the majority of Yemen’s imports and vital aid shipments pass through.

    The mission’s future

    It also signals a growing debate over the mission’s future, requesting the Secretary-General to submit a review by November to enhance coordination and coherence of UN operations, “bearing in mind challenges” that have directly impeded UNMHA’s capacity to deliver.

    “The Security Council…expresses its intention to review the full range of options for UNMHA’s mandate, including assessing the future viability and sunsetting of the Mission, and make any necessary adjustments to gain efficiencies and reduce costs or otherwise, as may be required to UN operations in Hudaydah by developments on the ground, including inter alia a durable nationwide ceasefire,” the resolution noted.

    UNMHA was established in 2019 to support implementation of the Stockholm Agreement between the Government of Yemen and Ansar Allah (as the Houthis are formally known), which sought to prevent major conflict over the region.

    The mission monitors the ceasefire, facilitates redeployments and supports de-escalation through liaison mechanisms between the parties.

    Tensions mounting

    While the military situation on the ground remains tenuously stable, tensions are mounting on multiple fronts.

    According to a letter from the Secretary-General to the 15-member Council in June, a growing number of ceasefire violations – averaging over 100 per day between June 2024 and May 2025 – highlight the fragile state of the region.  

    Government-aligned forces fortified positions in anticipation of a possible offensive on the city, while Houthi units increased infiltration attempts and public mobilisation, including military-style youth camps in areas they control.

    UN Photo/Mark Garten

    Security Council unanimously adopts Resolution 2786 (2025) extending until 28 January 2026 the mandate of the UN Mission to support the Hudaydah Agreement (UNMHA).

    Deadly Red Sea passage

    Compounding this, Houthi attacks on international shipping in the Red Sea have intensified. On 8 July, the commercial vessel Eternity C was sunk, killing several crew members and leaving others missing. This followed the sinking of the Magic Seas vessel two days earlier.

    In a statement, UN Special Envoy Hans Grundberg condemned the attacks, calling them violations of international maritime law and warning they risked serious environmental and geopolitical fallout.

    He called on Ansar Allah to cease attacks that risk escalating tensions in and around Yemen.

    “[He urges them] to build on the cessation of hostilities with the United States in the Red Sea and to provide durable guarantees to the region and the wider international community, ensuring the safety of all those using this critical waterway,” the statement noted.

    Significant operational constraints

    Within Hudaydah itself, UNMHA faces significant constraints.  

    The June letter by the Secretary-General details restrictions by Houthi authorities on UN patrols to the critical Red Sea ports – Hudaydah, Salif and Ras Issa.

    Damage from repeated airstrikes, including by the US and Israel in response to Houthi attacks, has left key port infrastructure partially inoperable, disrupting fuel, food and medical imports.

    With Hudaydah responsible for 70 per cent of Yemen’s commercial imports and 80 per cent of humanitarian deliveries, the stakes are high.

    © UNICEF/Mahmoud Alfilastini

    A child receives a polio vaccination in Yemen.

    Polio vaccination drive

    Meanwhile, a new round of polio vaccinations is underway in Government-controlled areas of southern Yemen, amid mounting concerns over the continued spread of the virus.  

    From 12 to 14 July, health workers deployed across 12 governorates, aimed at curbing the outbreak of variant type 2 poliovirus.

    The campaign, led by Yemen’s Ministry of Public Health with support from UN Children’s Fund (UNICEF) and World Health Organization (WHO), came as 282 cases have been reported since 2021, with environmental surveillance confirming ongoing transmission.

    “The campaign is essential to interrupt transmission and protect every child from the debilitating effects of polio,” said Ferima Coulibaly-Zerbo, acting WHO Representative in Yemen.

    UNICEF’s Peter Hawkins echoed the urgency, warning of the “imminent threat” to unvaccinated children if immunisation gaps persist.

    “But, through vaccination, we can keep our children safe,” he said.

    MIL OSI United Nations News –

  • MIL-OSI Submissions: Just back from holiday and not feeling well? Here are the symptoms you should take seriously

    Source: The Conversation – UK – By Dan Baumgardt, Senior Lecturer, School of Physiology, Pharmacology and Neuroscience, University of Bristol

    What are you bringing back with you? The Picture Studio/Shutterstock

    Summer is synonymous with adventure, with millions flocking to exotic destinations to experience different cultures, cuisines and landscapes. But what happens when the souvenir you bring back isn’t a fridge magnet or a tea towel, but a new illness?

    International travel poses a risk of catching something more than a run-of-the-mill bug, so it’s important to be vigilant for the telltale symptoms. Here are the main ones to look out for while away and when you return.

    Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK’s latest coverage of news and research, from politics and business to the arts and sciences.

    Fever

    Fever is a common symptom to note after international travel – especially to tropical or subtropical regions. While a feature of many different illnesses, it can be the first sign of an infection – sometimes a serious one.

    One of the most well-known travel-related illnesses linked to fever is malaria. Spread by mosquito bites in endemic regions, malaria is a protozoal infection that often begins with flu-like symptoms, such as headache and muscle aches, progressing to severe fever, sweating and shaking chills.

    Other signs can include jaundice (yellowing of the skin or eyes), swollen lymph nodes, rashes and abdominal pain – though symptoms vary widely and can mimic many other illnesses.

    Prompt medical attention is essential. Malaria is serious and can become life threatening. It’s also worth noting that symptoms may not appear until weeks or even months after returning home. In the UK, there are around 2,000 imported malaria cases each year.

    Travellers to at-risk areas are strongly advised to take preventative measures. This includes mosquito-bite avoidance as well as prescribed antimalarial medications, such as Malarone and doxycycline. Although these drugs aren’t 100% effective, they significantly reduce the risk of infection.

    Aside from malaria, other mosquito-borne diseases can cause fever. Dengue fever, a viral infection found in tropical and subtropical regions, leads to symptoms including high temperatures, intense headaches, body aches and rashes, which overlap with both malaria and other common viral illnesses.

    Most people recover with rest, fluids and paracetamol, but in some instances, dengue can become severe and requires emergency hospital treatment. A vaccine is also available – but is only recommended for people who have had dengue before, as it provides good protection in this group.

    Any fever after international travel should be taken seriously. Don’t brush it off as something you’ve just picked up on the plane – please see a doctor. A simple test could lead to early diagnosis and might save your life.

    Avoiding being bitten is a good defensive measure.
    Jaromir Chalabala/Shutterstock

    Diarrhoea

    Few travel-related issues are as common – or as unwelcome – as diarrhoea. It’s estimated that up to six in ten travellers will experience at least one episode during or shortly after their trip. For some, it’s an unpleasant disruption mid-holiday; for others, symptoms emerge once they’re back home.

    Traveller’s diarrhoea is typically caused by eating food or drinking water containing certain microbes (bacteria, viruses, parasites) or their toxins. Identifying the more serious culprits early is essential – especially when symptoms go beyond mild discomfort.

    Warning signs to look out for include large volumes of watery diarrhoea, visible blood in the stool or explosive bowel movements. These may suggest a more serious infection, such as giardia, cholera or amoebic dysentery.

    These conditions are more common in regions with poor sanitation and are especially prevalent in parts of the tropics.

    Some infections may require targeted antibiotics or antiparasitic treatment. But regardless of the cause, the biggest immediate risk with any severe diarrhoea is dehydration from copious fluid loss. In serious cases, hospital admission for intravenous fluids may be necessary.

    The key message for returning travellers: if diarrhoea is severe, persistent or accompanied by worrying symptoms, see a doctor. What starts as a nuisance could quickly escalate without the right care.

    And if you have blood in your stool, make sure you seek medical advice.

    Jaundice

    If you’ve returned from a trip with a change in skin tone, it may not just be a suntan. A yellowish tint to the skin – or more noticeably, the whites of the eyes – could be a sign of jaundice, another finding that warrants medical attention.

    Jaundice is not a disease itself, but a visible sign that something may be wrong with either the liver or blood. It results from a buildup of bilirubin, a yellow pigment that forms when red blood cells break down, and which is then processed by the liver.

    Signs of jaundice should be taken very seriously.
    sruilk/Shutterstock.com

    Several travel-related illnesses can cause jaundice. Malaria is one culprit as is the mosquito-borne yellow fever. But another common cause is hepatitis – inflammation of the liver.

    Viral hepatitis comes in several forms. Hepatitis A and E are spread via contaminated food or water – common in areas with poor sanitation. In contrast, hepatitis B and C are blood-borne, transmitted through intravenous drug use, contaminated medical equipment or unprotected sex.

    Besides jaundice, hepatitis can cause a range of symptoms, including fever, nausea, fatigue, vomiting and abdominal discomfort. A diagnosis typically requires blood tests, both to confirm hepatitis and to rule out other causes. While many instances of hepatitis are viral, not all are, and treatment depends on the underlying cause.

    As we’ve seen, a variety of unpleasant medical conditions can affect the unlucky traveller. But we’ve also seen that the associated symptoms are rather non-specific. Indeed, some can be caused by conditions that are short-lived and require only rest and recuperation to get over a rough few days. But the area between them is decidedly grey.

    So plan your trip carefully, be wary of high-risk activities while abroad – such as taking drugs or having unprotected sex – and stay alert to symptoms that develop during or after travel. If you feel unwell, don’t ignore it. Seek medical attention promptly to identify the cause and begin appropriate treatment.

    Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    – ref. Just back from holiday and not feeling well? Here are the symptoms you should take seriously – https://theconversation.com/just-back-from-holiday-and-not-feeling-well-here-are-the-symptoms-you-should-take-seriously-260013

    MIL OSI –

  • India cuts zero-dose children by 43% as South Asia hits record-high immunization in 2024

    Source: Government of India

    Source: Government of India (4)

    India has reduced the number of children who missed all vaccinations — also called zero-dose children — by 43% in just one year, according to new data released on Tuesday by WHO and UNICEF.

    As per the 2024 data, India brought down its number of zero-dose children from 1.6 million in 2023 to 0.9 million in 2024 — a drop of nearly 700,000.

    “This is a proud moment for South Asia. More children are protected today than ever before,” said Sanjay Wijesekera, UNICEF Regional Director for South Asia, while also stressing the need to reach the remaining children in remote areas.

    South Asia, as a region, achieved its highest-ever immunization coverage. In 2024, 92% of infants received the third dose of the DTP vaccine, which protects against diphtheria, tetanus and pertussis. This marks a 2% increase from 2023 and even surpasses pre-COVID levels.

    Nepal also saw major improvement, cutting its number of zero-dose children by more than half. Pakistan reached its highest-ever DTP3 coverage at 87%. However, Afghanistan remains a concern, with the lowest coverage in the region and a slight decline compared to last year.

    Measles coverage improved as well: around 93% of infants received the first dose and 88% received the second. Reported measles cases fell sharply by 39% in 2024.

    Vaccination against HPV (Human Papillomavirus), which prevents cervical cancer, also made progress. Bangladesh vaccinated over 7.1 million girls since launching its programme last year, while Bhutan, Maldives and Sri Lanka also reported increases. India and Pakistan are expected to begin their HPV vaccination campaigns later this year.

    The WHO and UNICEF report praised strong leadership from governments, the tireless work of frontline health workers, and the better use of data and technology for achieving these gains.

    “It is heartening to see the WHO South-East Asia Region reach its highest-ever immunization rates, surpassing the pre-pandemic uptrend. We must build on this momentum and step up efforts to reach every child with these lifesaving vaccines. Together we can, and we must,” said Dr Thaksaphon Thamarangsi, Director of Programme Management, WHO South-East Asia Region.

    Still, experts warned that over 2.9 million children in South Asia remain un- or under-vaccinated and must be reached to ensure full protection against deadly diseases.

    (ANI)

  • MIL-OSI United Nations: 15 July 2025 Turkmenistan strengthens its influenza vaccination programme

    Source: World Health Organisation

    Building pandemic response capacities through seasonal vaccination 

    Strong national influenza vaccination programmes are the foundation for the vaccination component of the pandemic response. With support from the World Health Organization (WHO) Pandemic Influenza Preparedness (PIP) Framework’s Partnership Contribution (PC), Turkmenistan is enhancing its national seasonal influenza vaccination programme and through this, is strengthening its preparedness for future pandemics. This collaboration is part of a broader effort to build resilient health systems capable of responding to influenza epidemics and pandemics. 

    Over the past eight years, the Ministry of Health has expanded access to influenza vaccines for WHO-recommended priority groups, including health workers, older adults, people with chronic conditions, and pregnant women. The annual influenza vaccination programme not only protects vulnerable populations but also serves as a foundation for pandemic response.

    Reviewing the influenza vaccination programme  

    In May 2025, Turkmenistan became the first country in the WHO European Region to use the Facilitated Assessment of Influenza Vaccination Programme Review (FAIR) tool. During the review and an interactive workshop, WHO technical experts collaborated with the Ministry of Health to evaluate best practices and identify priority actions to strengthen the national vaccination programme. 

    Using the FAIR tool, WHO experts conducted informational interviews with national stakeholders responsible for policy development, evidence generation, cold chain and supply management, risk communication, community engagement, integrated service delivery, and data management. In addition, WHO experts and national counterparts visited Turkmenistan’s main vaccine storage facilities and a local polyclinic administering influenza vaccines.

    From assessment to action 

    During the workshop, WHO experts presented FAIR findings and facilitated group discussions with national focal points. Together, they developed a list of priority actions, including:

    • Developing a national seasonal influenza vaccination policy aligned with WHO guidance 
    • Reviewing and updating coverage data 
    • Conducting studies to assess the impact of influenza vaccination

    The workshop also emphasized the role of seasonal influenza vaccination as a platform for broader pandemic preparedness. In this context, WHO and national focal points conducted a simulation exercise focused on planning and deploying pandemic vaccines, drawing on lessons from the COVID-19 response. Participants from emergency vaccination, logistics, regulatory affairs, and communications identified areas for improvement in the national deployment and vaccination plan (NDVP). 

    Commitment to resilience 

    Turkmenistan is committed to advancing its national influenza preparedness and strengthening its health system’s resilience. By addressing both seasonal and pandemic influenza, the country is taking important steps to protect its population and enhance its capacity to respond to emergencies.

    MIL OSI United Nations News –

  • MIL-OSI United Kingdom: Director’s public health report draws parallels with Leicester’s past

    Source: City of Leicester

    LEICESTER’S public health journey since the Victorian era is captured in a powerful new report by the city’s director of public health.

    In his annual report for 2024-2025, Rob Howard looks back at the challenges of the last 12 months within the context of the city’s past, from deadly outbreaks of smallpox in the 19th century to the slum clearance programme of the 20th century and the COVID-19 pandemic of 2020.

    Using records from the city council’s archives, he highlights how issues faced by the public health pioneers of the past – such as vaccine resistance, housing quality, fuel poverty and inequality – remain challenges today.

    “The past holds vital clues to the present,” said Mr Howard.

    “By drawing lessons from history, we can see that effective public health depends not just on medical advances, but on earning the trust of the people we serve.

    “Resistance to the smallpox vaccination in the 1850s, for example, echoes the public debates of today – but thanks to good communication and an approach that’s culturally sensitive, we are now getting our message across, encouraging the take-up of vaccines and helping to reduce the spread of infectious disease.”

    Other key themes in the report include the ongoing impact of poverty and poor housing on health outcomes, and the resurgence of diseases such as tuberculosis (TB) and measles.

    A significant measles outbreak in 2024 and the highest TB notification rate in England highlight Leicester’s persistent public health challenges.

    “Over the past year, Leicester’s health landscape has been shaped by a combination of enduring inequalities, a resurgence of infectious diseases and the continuing impacts of deprivation,” said Mr Howard.

    “Life expectancy remains below the national average, with residents living more years in ill health – particularly in the most deprived communities.

    “Fuel poverty continues to affect a large proportion of households, contributing to poor physical and mental health outcomes.

    “But despite these pressures, the city has demonstrated the strength of community-led responses – from mobile vaccination campaigns to energy advice outreach – and continues to invest in tackling health disparities through targeted, culturally sensitive public health strategies.”

    As well as looking to the past, the 40-page report also looks ahead, with a vision for public health in Leicester that blends evidence, compassion and collaboration. Those reading the report to its conclusion will find a twist in the final chapter, providing – perhaps – a hint of the future ahead.

    The History, Present and Future of Public Health in Leicester City is now available to download.

    MIL OSI United Kingdom –

  • MIL-OSI Africa: New foot-and-mouth disease detected in the Free State

    Source: Government of South Africa

    The Department of Agriculture has confirmed a new outbreak of foot-and-mouth disease (FMD) on a commercial farm in Moqhaka Local Municipality, within the Kroonstad State Veterinary in Free State.

    The outbreak was identified following epidemiological investigations and confirmed positive laboratory results.

    The department said the affected property was placed under quarantine on 8 July 2025, and immediate control measures were implemented, including surveillance and vaccination of livestock.

    “Trace-back activities are ongoing to determine the source of the infection, while farms in the surrounding 10km radius are undergoing surveillance to determine the possible extent of the spread,” the department said in a statement on Monday.

    Over 250 FMD cases reported in five provinces

    As of July 2025, South Africa has recorded a total of 270 FMD outbreaks across five provinces. Of these, 249 outbreaks remain unresolved, while 21 have been declared resolved.

    “KwaZulu-Natal has been the most affected province, with 191 reported outbreaks, of which 172 remain active and 19 have been resolved. Since May 2025, Gauteng has reported 32 outbreaks, North West has four open outbreaks, while Mpumalanga has reported three outbreaks,” the department said.

    The Eastern Cape has recorded 40 outbreaks, with 38 still open and two resolved. No new cases have been reported in Eastern Cape since September 2024.

    Correction on KZN Disease Management Area notice 

    Meanwhile, the department has issued a correction in a Government Gazette notice (Gazette Notice 6396 of 4 July 2025), which repeal the previous notice (Gazette Notice 5997 of 17 March 2025). 

    The department acknowledged that certain areas that still fall under the Disease Management Area (DMA) designation in KwaZulu-Natal were mistakenly omitted.

    “We sincerely apologise for any confusion caused and request all stakeholders to take note of the following areas that are declared to be part of the KwaZulu-Natal DMA,” the department said.

    The municipalities confirmed to remain within the DMA include the entire Big Five Hlabisa; Mtubatuba; Nongoma; Ulundi; Umhlabuyalingana; Jozini; Pongola; Abaqulusi; Umfolozi; uMhlathuze; Mthonjaneni; Nqutu; Nkandla; uMlalazi; and Mandeni.

    Other areas include the portion of the Emadlangeni Local Municipality, south of R34 from R33; Newcastle Local Municipality, south of R34 up to and east of N11; Dannhauser Local Municipality east of N11 and north of R68; Endumeni Local Municipality, north of R68 and east of R33; Msinga Local Municipality, east of R33; UMvoti Local Municipality, east of the R33 up to R74 and north of R74; Maphumulo Local Municipality, north-east of the R74; Ndwedwe Local Municipality, east of the R74; as well as portion of the KwaDukuza Local Municipality, north-east of R74 up to the N2 and west to the N2 up to Mandeni Local Municipality. – SAnews.gov.za
     

    MIL OSI Africa –

  • MIL-OSI United Nations: 15 July 2025 Joint News Release Global childhood vaccination coverage holds steady, yet over 14 million infants remain unvaccinated – WHO, UNICEF

    Source: World Health Organisation

    In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis (DTP)-containing vaccine, and 85% – roughly 109 million – completed all three doses, according to new national immunization coverage data released today by the World Health Organization (WHO) and UNICEF.

    Compared to 2023, around 171 000 more children received at least one vaccine, and one million more completed the full three-dose DTP series. While the gains are modest, they signal continued progress by countries working to protect children, even amid growing challenges.

    Still, nearly 20 million infants missed at least one dose of DTP-containing vaccine last year, including 14.3 million “zero-dose” children who never received a single dose of any vaccine. That’s 4 million more than the 2024 target needed to stay on track with Immunization Agenda 2030 goals, and 1.4 million more than in 2019, the baseline year for measuring progress.

    “Vaccines save lives, allowing individuals, families, communities, economies and nations to flourish,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “It’s encouraging to see a continued increase in the number of children being vaccinated, although we still have a lot of work to do. Drastic cuts in aid, coupled with misinformation about the safety of vaccines, threaten to unwind decades of progress. WHO remains committed to working with our partners to support countries to develop local solutions and increase domestic investment to reach all children with the lifesaving power of vaccines.”

    Children often remain un- or under-vaccinated due to a combination of factors, such as limited access to immunization services, disrupted supply, conflict and instability, or misinformation about vaccines.

    Access to vaccines remains deeply unequal

    Data from 195 countries show that 131 countries have consistently reached at least 90% of children with the first dose of DTP vaccine since 2019, but there has been no significant movement in expanding this group. Among the countries that reached less than 90% in 2019, only 17 managed to increase their coverage rates in the past five years. Meanwhile, in 47 countries, progress is stalling or worsening. This includes 22 countries that achieved and surpassed the 90% target in 2019 but have since declined.

    The data shows conflict and humanitarian crises can quickly erode vaccination progress. A quarter of the world’s infants live in just 26 countries affected by fragility, conflict, or humanitarian crises, yet they make up half of all unvaccinated children globally. Concerningly, in half of these countries the number of unvaccinated children has expanded rapidly from 3.6 million in 2019 to 5.4 million in 2024, underscoring the need for humanitarian responses to include immunization.

    Immunization coverage in the 57 low-income countries supported by Gavi, the Vaccine Alliance have improved in the past year, reducing the number of un- and under-vaccinated children by roughly 650 000. At the same time, signs of slippage are emerging in upper-middle- and high-income countries that have previously maintained at least 90% coverage. Even small declines in immunization coverage can dramatically raise the risk of disease outbreaks and place additional strain on already overstretched health systems.

    “The good news is that we have managed to reach more children with life-saving vaccines. But millions of children remain without protection against preventable diseases, and that should worry us all,” said UNICEF Executive Director Catherine Russell. “We must act now with determination to overcome barriers like shrinking health budgets, fragile health systems along with misinformation and access constraints because of conflicts. No child should die from a disease we know how to prevent.”

    Broadening protection against vaccine-preventable diseases

    Despite these challenges, countries – especially those supported by Gavi – continue to introduce and scale up vaccines, including against human papillomavirus (HPV), meningitis, pneumococcal disease, polio, and rotavirus.

    For example, large national scale-ups of the HPV vaccine and revitalization efforts in countries that have previously introduced the vaccine, have boosted global coverage by 4% in the past year. In 2024, 31% of eligible adolescent girls globally received at least 1 dose of the HPV vaccine – most doses were administered in countries using a single-dose schedule. While far from the 90% coverage target by 2030, it represents a substantial increase from the 17% coverage in 2019.

    “In 2024, lower-income countries protected more children than ever before, with coverage rates increasing across all Gavi-supported vaccines,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “Yet population growth, fragility and conflict present major hurdles to achieving equity, leaving the most vulnerable children and communities at risk. Continued commitment from governments and partners will be critical to saving lives and protecting the world from infectious disease threats.”

    Coverage against measles also improved, with 84% of children receiving the first dose and 76% receiving the second dose, which shows slight increase from the previous year. An estimated 2 million more children were reached in 2024, but the overall coverage rate is far below the 95% needed in every community to prevent outbreaks.

    This results in more than 30 million children remaining under-protected against measles, leading to more large or disruptive outbreaks. In 2024, the number of countries experiencing large or disruptive measles outbreaks rose sharply to 60, nearly doubling from 33 in 2022.

    The promise of protecting every child is at risk

    Although the community demand for childhood vaccination remains high and protection against more diseases is expanding, the latest estimates highlight a concerning trajectory. National and global funding shortfalls, growing instability worldwide, and rising vaccine misinformation threaten to further stall or even reverse progress which would risk increases in severe disease and deaths from vaccine-preventable diseases.

    WHO and UNICEF call on governments and relevant partners to:

    • close the funding gap for Gavi’s next strategic cycle (2026–2030) to protect millions of children in lower-income countries and global health security;
    • strengthen immunization in conflict and fragile settings to reach more zero-dose children and prevent deadly disease outbreaks;
    • prioritize local-led strategies and domestic investment, embedding immunization firmly within primary health care systems to close equity gaps;
    • counter misinformation and further increase vaccine uptake through evidence-based approaches; and
    • invest in stronger data and disease surveillance systems to guide high-impact immunization programmes.
       

    Notes to editors 

    WHO and UNICEF are working with Gavi, the Vaccine Alliance and other partners to deliver the global Immunization Agenda 2030 (IA2030), a strategy for all countries and relevant global partners to achieve set goals on preventing diseases through immunization and delivering vaccines to everyone, everywhere, at every age.

    About the data 

    Based on country-reported data, the WHO and UNICEF estimates of national immunization coverage (WUENIC) provide the world’s largest and most comprehensive dataset on immunization trends for vaccinations against 14 diseases given through regular health systems – normally at clinics, community centres, outreach services, or health worker visits. For 2024, data were provided from 189 countries. 

    About WHO 

    Dedicated to the health and well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere, an equal chance at a safe and healthy life. We are the UN agency for health. We connect nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int

    About UNICEF

    UNICEF, the United Nations agency for children, works to protect the rights of every child, everywhere, especially the most disadvantaged children and in the toughest places to reach. Across more than 190 countries and territories, we do whatever it takes to help children survive, thrive, and fulfil their potential.

    For more information about UNICEF and its work, please visit: www.unicef.org
    Follow UNICEF on X (Twitter), Facebook, Instagram, and YouTube

    MIL OSI United Nations News –

  • MIL-OSI United Nations: 15 July 2025 Joint News Release Global childhood vaccination coverage holds steady, yet over 14 million infants remain unvaccinated – WHO, UNICEF

    Source: World Health Organisation

    In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis (DTP)-containing vaccine, and 85% – roughly 109 million – completed all three doses, according to new national immunization coverage data released today by the World Health Organization (WHO) and UNICEF.

    Compared to 2023, around 171 000 more children received at least one vaccine, and one million more completed the full three-dose DTP series. While the gains are modest, they signal continued progress by countries working to protect children, even amid growing challenges.

    Still, nearly 20 million infants missed at least one dose of DTP-containing vaccine last year, including 14.3 million “zero-dose” children who never received a single dose of any vaccine. That’s 4 million more than the 2024 target needed to stay on track with Immunization Agenda 2030 goals, and 1.4 million more than in 2019, the baseline year for measuring progress.

    “Vaccines save lives, allowing individuals, families, communities, economies and nations to flourish,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “It’s encouraging to see a continued increase in the number of children being vaccinated, although we still have a lot of work to do. Drastic cuts in aid, coupled with misinformation about the safety of vaccines, threaten to unwind decades of progress. WHO remains committed to working with our partners to support countries to develop local solutions and increase domestic investment to reach all children with the lifesaving power of vaccines.”

    Children often remain un- or under-vaccinated due to a combination of factors, such as limited access to immunization services, disrupted supply, conflict and instability, or misinformation about vaccines.

    Access to vaccines remains deeply unequal

    Data from 195 countries show that 131 countries have consistently reached at least 90% of children with the first dose of DTP vaccine since 2019, but there has been no significant movement in expanding this group. Among the countries that reached less than 90% in 2019, only 17 managed to increase their coverage rates in the past five years. Meanwhile, in 47 countries, progress is stalling or worsening. This includes 22 countries that achieved and surpassed the 90% target in 2019 but have since declined.

    The data shows conflict and humanitarian crises can quickly erode vaccination progress. A quarter of the world’s infants live in just 26 countries affected by fragility, conflict, or humanitarian crises, yet they make up half of all unvaccinated children globally. Concerningly, in half of these countries the number of unvaccinated children has expanded rapidly from 3.6 million in 2019 to 5.4 million in 2024, underscoring the need for humanitarian responses to include immunization.

    Immunization coverage in the 57 low-income countries supported by Gavi, the Vaccine Alliance have improved in the past year, reducing the number of un- and under-vaccinated children by roughly 650 000. At the same time, signs of slippage are emerging in upper-middle- and high-income countries that have previously maintained at least 90% coverage. Even small declines in immunization coverage can dramatically raise the risk of disease outbreaks and place additional strain on already overstretched health systems.

    “The good news is that we have managed to reach more children with life-saving vaccines. But millions of children remain without protection against preventable diseases, and that should worry us all,” said UNICEF Executive Director Catherine Russell. “We must act now with determination to overcome barriers like shrinking health budgets, fragile health systems along with misinformation and access constraints because of conflicts. No child should die from a disease we know how to prevent.”

    Broadening protection against vaccine-preventable diseases

    Despite these challenges, countries – especially those supported by Gavi – continue to introduce and scale up vaccines, including against human papillomavirus (HPV), meningitis, pneumococcal disease, polio, and rotavirus.

    For example, large national scale-ups of the HPV vaccine and revitalization efforts in countries that have previously introduced the vaccine, have boosted global coverage by 4% in the past year. In 2024, 31% of eligible adolescent girls globally received at least 1 dose of the HPV vaccine – most doses were administered in countries using a single-dose schedule. While far from the 90% coverage target by 2030, it represents a substantial increase from the 17% coverage in 2019.

    “In 2024, lower-income countries protected more children than ever before, with coverage rates increasing across all Gavi-supported vaccines,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “Yet population growth, fragility and conflict present major hurdles to achieving equity, leaving the most vulnerable children and communities at risk. Continued commitment from governments and partners will be critical to saving lives and protecting the world from infectious disease threats.”

    Coverage against measles also improved, with 84% of children receiving the first dose and 76% receiving the second dose, which shows slight increase from the previous year. An estimated 2 million more children were reached in 2024, but the overall coverage rate is far below the 95% needed in every community to prevent outbreaks.

    This results in more than 30 million children remaining under-protected against measles, leading to more large or disruptive outbreaks. In 2024, the number of countries experiencing large or disruptive measles outbreaks rose sharply to 60, nearly doubling from 33 in 2022.

    The promise of protecting every child is at risk

    Although the community demand for childhood vaccination remains high and protection against more diseases is expanding, the latest estimates highlight a concerning trajectory. National and global funding shortfalls, growing instability worldwide, and rising vaccine misinformation threaten to further stall or even reverse progress which would risk increases in severe disease and deaths from vaccine-preventable diseases.

    WHO and UNICEF call on governments and relevant partners to:

    • close the funding gap for Gavi’s next strategic cycle (2026–2030) to protect millions of children in lower-income countries and global health security;
    • strengthen immunization in conflict and fragile settings to reach more zero-dose children and prevent deadly disease outbreaks;
    • prioritize local-led strategies and domestic investment, embedding immunization firmly within primary health care systems to close equity gaps;
    • counter misinformation and further increase vaccine uptake through evidence-based approaches; and
    • invest in stronger data and disease surveillance systems to guide high-impact immunization programmes.
       

    Notes to editors 

    WHO and UNICEF are working with Gavi, the Vaccine Alliance and other partners to deliver the global Immunization Agenda 2030 (IA2030), a strategy for all countries and relevant global partners to achieve set goals on preventing diseases through immunization and delivering vaccines to everyone, everywhere, at every age.

    About the data 

    Based on country-reported data, the WHO and UNICEF estimates of national immunization coverage (WUENIC) provide the world’s largest and most comprehensive dataset on immunization trends for vaccinations against 14 diseases given through regular health systems – normally at clinics, community centres, outreach services, or health worker visits. For 2024, data were provided from 189 countries. 

    About WHO 

    Dedicated to the health and well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere, an equal chance at a safe and healthy life. We are the UN agency for health. We connect nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int

    About UNICEF

    UNICEF, the United Nations agency for children, works to protect the rights of every child, everywhere, especially the most disadvantaged children and in the toughest places to reach. Across more than 190 countries and territories, we do whatever it takes to help children survive, thrive, and fulfil their potential.

    For more information about UNICEF and its work, please visit: www.unicef.org
    Follow UNICEF on X (Twitter), Facebook, Instagram, and YouTube

    MIL OSI United Nations News –

  • MIL-Evening Report: A person in the US has died from pneumonic plague. It’s not just a disease of history

    Source: The Conversation (Au and NZ) – By Thomas Jeffries, Senior Lecturer in Microbiology, Western Sydney University

    Corona Borealis Studio/Shutterstock

    A person in Arizona has died from the plague, local health officials reported on Friday.

    This marks the first such death in this region in 18 years. But it’s a stark reminder that this historic disease, though rare nowadays, is not just a disease of the past.

    So what actually is “plague”? And is it any cause for concern in Australia?

    There are 3 types of ‘plague’

    The word “plague” is often used to refer to any major disease epidemic or pandemic, or even to other undesirable events, such as a mouse plague. Naturally, the word can evoke fear.

    But scientifically speaking, plague is a disease caused by the bacterium Yersinia pestis.

    Plague has three main forms: bubonic, septicemic and pneumonic.

    Bubonic is the most common and is named after “buboes”, which are the painful, swollen lymph nodes the infection causes. Other symptoms include fever, headache, chills and weakness.

    Bubonic plague is typically spread by fleas living on animals such as rats, prairie dogs and marmots. If an infected flea moves from their animal host to bite a human, this can cause an infection.

    People can also become infected through handling an animal infected with the disease.

    Septicemic plague occurs if bubonic plague is left untreated, or it can occur directly if the disease enters the bloodstream. Septicemic plague causes bleeding into the organs. The name comes from septicemia, which refers to a serious blood infection.

    The recent death in the United States was due to a case of pneumonic plague, which is the most severe form. Bubonic plague can in some cases spread to the lungs, where it becomes pneumonic plague. However, pneumonic plague can also spread from person to person via tiny respiratory droplets, in a similar way to COVID. Symptoms are similar to the other forms but also include severe pneumonia.

    Some 30–60% of people who contract bubonic plague will die, while the fatality rate can be up to 100% for pneumonic plague if left untreated.

    Animals such as rats can carry the bacterium that causes plague.
    marcus_photo_uk/Shutterstock

    Plague: a potted history

    This disease is one of the most important in history. The Plague of Justinian (541–750CE) killed tens of millions of people in the western Mediterranean, heavily impacting the expansion of the Byzantine Empire.

    The medieval Black Death (1346–53) was also seismic, killing tens of millions of people and up to half of Europe’s population.

    Spread by the growing trade networks of the British empire, the third and most recent plague pandemic spanned the years 1855 until roughly 1960, peaking in the early 1900s. It was responsible for 12 million deaths, primarily in India, and even reached Australia.

    It’s believed the bubonic plague was largely behind these pandemics.

    Plague in the modern day

    First introduced into the US during the third pandemic, plague infects an average of seven people a year in the west of the country, due to being endemic in groundhog and prairie dog populations there. The last major outbreak was 100 years ago.

    Deaths are very rare, with 14 deaths in the past 25 years in the US.

    Globally, there have been a few thousand cases of plague over the past decade.

    The countries with the most cases currently include the Democratic Republic of the Congo, Madagascar and Peru, with cases also occurring in India, central Asia and the US. Cases usually occur in rural and agricultural areas.

    Plague can be treated

    Plague can easily be treated with common antibiotics, typically a course of 10–14 days, which can include both oral and intravenous antibiotics. But it must be treated quickly.

    The recent death is concerning, as it involves the airborne pneumonic form of the disease, the only form that spreads easily from person to person. But there’s no evidence of further spread of the disease within the US at this stage.

    As Y. pestis is not found in Australian animals, there is little risk here. Plague has not been reported in Australia in more than a century.

    But plague, like many diseases, is influenced by environmental conditions. The risk of climate change causing an expansion in the habitat of animal hosts means public health experts around the world should continue to monitor it closely.

    The plague, though often perceived as a disease of history, is still with us and can pose a major health threat if not treated early.

    Thomas Jeffries does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    – ref. A person in the US has died from pneumonic plague. It’s not just a disease of history – https://theconversation.com/a-person-in-the-us-has-died-from-pneumonic-plague-its-not-just-a-disease-of-history-261088

    MIL OSI Analysis – EveningReport.nz –

  • MIL-OSI: $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Signature Bank of Georgia (OTCMKTS: SGBG)

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Signature Bank of Georgia (OTCMKTS: SGBG) related to its merger with First Community Corporation. Upon completion of the proposed transaction, Signature Bank shareholders will receive 0.6410 shares of First Community common stock per Signature Bank share. Is it a fair deal?

    Click here for more info https://monteverdelaw.com/case/signature-bank-of-georgia/. It is free and there is no cost or obligation to you.

    NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:

    1. Do you file class actions and go to Court?
    2. When was the last time you recovered money for shareholders?
    3. What cases did you recover money in and how much?

    About Monteverde & Associates PC

    Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

    No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

    Contact:
    Juan Monteverde, Esq.
    MONTEVERDE & ASSOCIATES PC
    The Empire State Building
    350 Fifth Ave. Suite 4740
    New York, NY 10118
    United States of America
    jmonteverde@monteverdelaw.com
    Tel: (212) 971-1341

    Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

    The MIL Network –